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The Integrin Equilibrium: Balancing Protein-Protein and Protein-Lipid interactions
Abstract
On circulating platelets, the integrin fibrinogen receptor &alphaIIb&beta3 favors inactive conformations.
Platelets rapidly activate &alphaIIb&beta3 to bind fibrinogen, mediating a platelet clot. Resting
&alphaIIb&beta3 is stabilized by interactions between the &alphaIIb and &beta3 transmembrane domains.
Binding of talin-1 and kindlin-3 to the integrin cytoplasmic domain stabilizes separation of the TMs and
receptor activation. Src family kinases are needed for transmission of extracellular signals into the cell.
We have sought to better understand how signals are transmitted across the &alphaIIb&beta3 TM
domain. First we characterized the structure and dynamics of the active and inactive integrin cytoplasmic
domain to determine how motifs that bind talin-1 and kindlin-3 are affected by the integrin activation state
and the membrane environment. The &alphaIIb&beta3 cytoplasmic domain is disorded, while the &beta3
subunit contains two &alpha-helices, which interact with the phospholipid bilayer. The close proximity of
&alphaIIb to &beta3 in the inactive state induces a kink that projects the &beta-chain parallel to the
membrane surface. This kink is likely to stabilize interactions between helices in &beta3 with the
membrane and possibly compete with binding to talin-1 and kindlin-3. The &beta3 cytoplasmic domain
becomes increasingly dynamic further from the membrane, suggesting that distal kindlin-3 binding
residues should be more accessible to interact with their binding partners. We also studied the interaction
between talin-1 and the &beta3 cytoplasmic domain to determine how the membrane environment
affects formation of the talin-1/&beta3 complex. The membrane significantly increases the affinity of
talin-1 for &beta3, but that the ternary integrin/talin-1/membrane complex is not significantly more stable
than the talin-1/membrane complex alone. We also performed preliminary experiments characterizing the
interaction between &alphaIIb&beta3 and both kindlin-3 and c-Src. Unlike talin-1, kindlin-3 does not require
the membrane to bind the integrin cytoplasmic domain with high affinity. The interaction between c-Src
and the integrin was extremely weak suggesting that it might require colocalization through other
interactions. Finally, we developed a simplified model showing how thermodynamic coupling between
integrin subunits might allow &alphaIIb&beta3 to adopt multiple activation states.
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ABSTRACT

THE INTEGRIN EQUILIBRIUM: BALANCING PROTEIN-PROTEIN AND
PROTEIN-LIPID INTERACTIONS

David T. Moore

William F. DeGrado

On circulating platelets, the integrin fibrinogen receptor αIIbβ3 favors
inactive conformations. Platelets rapidly activate αIIbβ3 to bind fibrinogen,
mediating a platelet clot.

Resting αIIbβ3 is stabilized by interactions

between the αIIb and β3 transmembrane domains. Binding of talin-1 and
kindlin-3 to the integrin cytoplasmic domain stabilizes separation of the
TMs and receptor activation. Src family kinases are needed for
transmission of extracellular signals into the cell.

We have sought to

better understand how signals are transmitted across the αIIbβ3 TM
domain. First we characterized the structure and dynamics of the active
and inactive integrin cytoplasmic domain to determine how motifs that
bind talin-1 and kindlin-3 are affected by the integrin activation state and
the membrane environment. The αIIb cytoplasmic domain is disorded,
while the β3 subunit contains two α-helices, which interact with the
iv

phospholipid bilayer. The close proximity of αIIb to β3 in the inactive state
induces a kink that projects the β-chain parallel to the membrane surface.
This kink is likely to stabilize interactions between helices in β3 with the
membrane and possibly compete with binding to talin-1 and kindlin-3. The
β3 cytoplasmic domain becomes increasingly dynamic further from the
membrane, suggesting that distal kindlin-3 binding residues should be
more accessible to interact with their binding partners. We also studied
the interaction between talin-1 and the β3 cytoplasmic domain to
determine how the membrane environment affects formation of the talin1/β3 complex. The membrane siginificantly increases the affinity of talin-1
for β3, but that the ternary integrin/talin-1/membrane complex is not
significantly more stable than the talin-1/membrane complex alone. We
also performed preliminary experiments characterizing the interaction
between αIIbβ3 and both kindlin-3 and c-Src. Unlike talin-1, kindlin-3 does
not require the membrane to bind the integrin cytoplasmic domain with
high affinity.

The interaction between c-Src and the integrin was

extremely weak suggesting that it might require colocalization through
other interactions. Finally, we developed a simplified model showing how
thermodynamic coupling between integrin subunits might allow αIIbβ3 to
adopt multiple activation states.

v

Table of Contents
Chapter 1 Background............................................................................... 1
I. Introduction ......................................................................................... 1
II. Platelet integrins. ............................................................................... 2
Chapter 2 NMR analysis of the αIIb β3 cytoplasmic interaction suggests a
mechanism for integrin regulation.............................................................. 8
Abstract .................................................................................................. 8
I. Introduction ........................................................................................ 9
II. Results ............................................................................................ 11
Model αIIbβ3 cytoplasmic domain constructs. .................................. 11
Association of the αIIb and β3 cytoplasmic domains influences their
conformation. .................................................................................... 17
Structure of the β3 cytoplasmic domain crosslinked to the αIIb peptide
......................................................................................................... 21
Conformational flexibility of the αIIbβ3 cytoplasmic domains in
micelles ............................................................................................ 23
Conformational flexibility of the αIIbβ3 cytoplasmic domain in
phospholipid bilayers. ....................................................................... 26
III. Discussion...................................................................................... 31
IV. Methods .......................................................................................... 37
Supplemental ....................................................................................... 49
Chapter 3 The affinity of talin-1 for the β3-integrin cytosolic domain is
determined by its phospholipid bilayer environment. ............................... 51
Abstract ................................................................................................ 51
I. Introduction ...................................................................................... 52
II. Results ............................................................................................ 58
The talin-1 FERM domain contains an extended positively-charged
surface.............................................................................................. 58
Binding of the talin-1 FERM domain fragment F2F3 to negativelycharged phospholipids. .................................................................... 60
Binding of talin-1 FERM domain and its subdomains to PtdIns(4,5)P2.
......................................................................................................... 64
Enthalpy of talin-1 FERM domain binding to PtdIns(4,5)2................. 66
Talin-1 FERM domain binding to the β3 CT immobilized on negatively
charged carboxymethylated dextran. ............................................... 72
Binding of the talin-1 FERM domain to the β3 CT domain tethered to
negatively-charged bilayer................................................................ 74
III. Discussion...................................................................................... 79
IV. Methods ......................................................................................... 84
Chapter 4 Transmembrane communication: general principles and
lessons integrins and other receptors. ..................................................... 89
I. Introduction ...................................................................................... 89
II. Results ............................................................................................ 90
vi

The coupling of ligand binding and environmental effects to
conformational changes ................................................................... 90
Simple models for energetic coupling ............................................... 93
Inside-to-Outside Coupling in Integrins Receptors ......................... 102
IV. Coupling between integrin and kindlin subdomains produces distinct
integrin activation states. ................................................................... 107
Thermodynamic coupling between extracellular, TM, and cytoplasmic
domains allows dynamic regulation of ligand binding. .................... 111
Coupling between talin-1 and kindlin-3 produces distinct functional
states. ............................................................................................. 116
Chapter 5. Conclusions ......................................................................... 120
Appendix 1. Preliminary investigations of the interaction between kindlin-3
and αIIbβ3 ............................................................................................. 123
I. Introduction. ................................................................................... 123
II. Results .......................................................................................... 125
Purification of kindlin-3 from human platelets. ................................ 125
Preliminary experiments suggest kindlin-3 binds β3 with high affinity
in the absence of bilayers. .............................................................. 128
III. Methods ....................................................................................... 130
Appendix 2. NMR studies of the c-Src SH3 domain and the β3
cytoplasmic domain. .............................................................................. 132
I. Introduction .................................................................................... 132
II. Results .......................................................................................... 136
C-Src, β3 integrin, and polyproline constructs. ............................... 136
Circular dichroism and Trp-fluorescence of c-Src SH3 domain and the
β3 C-terminus. ................................................................................ 137
NMR titration of the β3 cytoplasmic domain the c-Src SH3 domain.
....................................................................................................... 141
III. Discussion.................................................................................... 146
IV. Methods ....................................................................................... 149
References ............................................................................................ 152

vii

List of Tables
Table S2.2.1 Summary of β3 structure statistics ..................................... 49
Table 3.1 Steady-state SPR measurements of talin-1 F2F3 subdomain
binding to phospholipids. .................................................................. 63
Table 3.2 Steady-state SPR measurements of talin FERM domain binding
to phospholipid bilayers containing 10% PtdIns(4,5)P2. ................... 65
Table 3.3 ITC measurements of talin-1 FERM domain and PLC-δ1 binding
to PtdIns(4,5)P2 and Ins(1,4,5)P3. .................................................. 68
Table 3.4 Steady-state SPR measurements of talin F0-F3 domain binding
to phospholipid bilayers containing 10%, 3%, and 1% PtdIns(4,5)P2.
......................................................................................................... 70
Table 3.5 ITC measurements of talin-1 FERM domain binding to the β3
CT attached to large unilamellar phospholipid vesicles (LUVs). ....... 78

viii

List of Figures
Figure 1.1 Simplified integrin equilibrium. ................................................. 3
Figure 2.1 The sequences of the αIIbβ3 TM and cytoplasmic domains and
experimental constructs used. .......................................................... 12
Figure 2.2 The αIIbβ3 cytoplasmic domain heterodimer construct before
and after reducing its disulfide bond. ................................................ 14
Figure 2.3 Mass spectra of membrane tethered αIIbβ3 cytoplasmic
domains. ........................................................................................... 16
Figure 2.4 Interaction between αIIb and β3 cytoplasmic domains. ......... 20
Figure 2.5 The structure of the β3 cytoplasmic domain. ......................... 22
Figure 2.6 Backbone dynamics of the αIIbβ3 cytoplasmic domain
heterodimer. ..................................................................................... 25
Figure 2.7 Circular dichroism confirms that interactions with phospholipids
stabilizes a helical conformation. ...................................................... 28
Figure 2.8 HDX-MS of the αIIbβ3 cytoplasmic domain in phospholipid
bilayers. ............................................................................................ 30
Figure 2.9 A linked equilibrium describing the activation of αIIbβ3 by
intracellular signaling molecules. ...................................................... 35
Figure 3.1 Comparison of the Talin-1 and Radixin FERM domains. ........ 54
Figure 3.2 Talin-1 and αIIbβ3 constructs used. ....................................... 58
Figure 3.3 Orientation of the talin-1 FERM domain with respect to the
inner leaflet of the plasma membrane. ............................................. 59
Figure 3.4 Steady state binding of the talin-1 FERM domain and its
subdomains to phospholipid bilayers. ............................................... 63
Figure 3.5 Comparison of PLC-δ1 PH domain and talin-1 FERM domain
binding to PtdIns(4,5)P2 and Ins(1,4,5)P2. ........................................ 67
Figure 3.6 Titration of Ins(1,4,5)P3 into talin-1 F0-F3 does not generate
significant enthalpy. .......................................................................... 71
Figure 3.7. Talin-1 FERM domain binding to the β3 CT immobilized on
negatively-charged surfaces or free in solution. ............................... 73
Figure 3.8. Talin-1 FERM domain binding to the β3 CT conjugated to
phospholipid bilayers containing 1% PtdIns(4,5)P2. ......................... 76
Figure 3.9 FERM domain binding to the β3 CT conjugated to negativelycharged phospholipid bilayers. ......................................................... 78
Figure 4.1 Simple linked-equilibria models. ............................................. 96
Figure 4.2 A more complex model of a signaling molecule. .................... 99
Figure 4.3 A realistic model of signal transduction, inspired by VirA protein
of the VirA/VirG two-component system. ........................................ 101
Figure 4.4 Thermodynamic model of integrin signaling. ........................ 103
Figure 4.5 Coupled equilibria linking integrin TM interactions to cytosolic
events. ............................................................................................ 106
Figure 4.6 Simplified domain structure of αIIbβ3. .................................. 109
Figure 4.7 Binding of regulatory proteins to the integrin cytoplasmic tail
affects receptor occupancy............................................................. 113
ix

Figure 4.8 Thermodynamic coupling between subdomains increases
ligand binding dynamic range. ........................................................ 116
Figure 4.9 Multiple integrin regulators can produce diverse activation
states. ............................................................................................. 118
Figure A1.1 Purification of Kindlin-3 from platelets. ............................... 127
Figure A1.2 Equilibrium AUC of Kindlin-3 and β3. ................................. 130
Figure A2.1 Domain structure of c-Src in its inactive conformation. ..... 134
Figure A2.2. The interaction between the c-Src SH3 domain and a
polyproline peptide. ........................................................................ 136
Figure A2.3 Comparison of CD and Trp fluorescence changes in the
presence of a polyproline peptide and β3-NITYRGT. .................... 140
Figure A2.4 Changes in SH3 chemical shift in the presence of β3NITYRGT........................................................................................ 142
Figure A2.5 β3-NITYRGT causes chemical shift changes centered around
the SH3 specificity pocket. ............................................................. 144
Figure A2.6 1N-15N HSQC titration of β3-cytoplasmic domain and c-Src
SH3. ............................................................................................... 146

x

Chapter 1 Background
I. Introduction
In multicellular organisms, integral membrane proteins mediate
adhesion and signal transduction across the plasma membrane. Such
processes are often dynamically regulated and reversible, suggesting that
they can be described as linked equilibria.
oligomeric

state,

or

protein-protein

Changes in conformation,

contacts

in

extracellular,

transmembrane (TM), and cytoplasmic domains can shift the equilibrium
between different receptor functional states and transmit information
across the membrane. In order to develop effective therapies to target
signaling receptors, these equilibria must be understood to prevent
undesired side effects. The importance of understanding these processes
is illustrated by the platelet fibrinogen receptor integrin, αIIbβ3.

Small

molecules that mimic fibrinogen successfully block ligand binding to
αIIbβ3, but stabilize active receptor conformations, resulting in either a
paradoxical prothrombotic state or clearance of platelets and severe
bleeding. In the following chapters, the regulation of αIIbβ3 is discussed.
In particular, we focus on the mechanisms of transmembrane signal
transduction and how coupled protein-protein and protein-lipid interactions
allow multidomain receptors such as αIIbβ3 to integrate multiple signals to
produce surprisingly diverse functions.
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II. Platelet integrins.
Platelets are highly specialized cell fragments that are released
from bone marrow megakaryocytes and are necessary for normal arterial
clotting (4). Functional thrombocytopenia in the presence of normal
platelet counts results from loss of the platelet fibrinogen receptor integrin
αIIbβ3.

The integrin αIIbβ3 mediates formation of the platelet clot and

patients whose platelets lack normal αIIbβ3 function present with the
bleeding diathesis Glanzmann thrombasthenia (5, 6).

Severe bleeding

can also result in patients with normal platelet counts and functional
integrins via loss of signal transduction molecules that regulate the αIIbβ3
(7-10).

Finally,

a

decreased

number

of

circulating

platelets

(thrombocytopenia) can result from spurious activation of the receptor by
small molecules or autoimmune antibodies (11).
Resting platelets circulate with αIIbβ3 in an inactive conformation.
In the presence of damaged vasculature, numerous signals are integrated
by the platelet, culminating in the activation of αIIbβ3, which binds
fibrinogen and von Willebrand’s factor to form a platelet plug (12). The
integrin family of receptors is ubiquitously expressed in metazoa (13).
Functional receptors are heterodimeric, composed of α and β subunits
(Figure 1.1).

Each subunit has a large ectodomain, a single

transmembrane domain, and a relatively short cytoplasmic domain. In

2

humans, there are eighteen α-chains and eight β-chains that combine to
form 24 integrin heterodimers. Although these receptors are differentially
expressed, recognize unique ligands, and occupy distinct functional
niches, they contain common structural elements.
transmembrane

and

cytoplasmic

domains

are

In particular the
highly

conserved,

consistent with their importance in regulating integrin function through
protein-protein interactions (14).

Figure 1.1 Simplified integrin equilibrium.
Integrins are in equilibrium between inactive (left) and active (right) states.
This equilibrium is modulated by both intracellular and extracellular
events.
Integrins possess highly modular domain structures that
communicate between each other establishing an elaborate coupled
equilibrium. Interactions between the intregrin TM domains stabilize the
3

inactive conformation.
Soluble factors can bind to each modular
subdomain and shift the equilibrium between states.

On a resting platelet, the transmembrane and membrane-proximal
domains of inactive αIIbβ3 form an extended heterodimeric interface (1517). Activation of αIIbβ3 requires TM domain separation. This separation
is dramatic (100 Å) and propagates to the ectodomain, stabilizing
significant conformational changes that allow ligand binding (18).

The

term “inside-out signaling” refers to the classical mode of integrin
activation in which intracellular signaling molecules bind to the integrin
cytoplasmic domain and stabilize separation of the α and β TM domains,
which results in subsequent activation of the extracellular ligand binding
site.

However, αIIbβ3 can also be activated through extracellular

interactions.

This suggests that the activation state of αIIbβ3 can be

described as a linked equilibrium in which intracellular, TM, and
cytoplasmic conformational states are coupled and either stabilized or
destabilized by interactions with other molecules.
Inside-out activation requires the evolutionarily related talin and
kindlin protein families (19, 20). There are two talin paralogs (talin-1 and
2) and three kindlin paralogs (kindlin-1, 2, and 3). In platelets, αIIbβ3
requires talin-1 and kindlin-3 only (21) (22). Patients who lack kindlin-3
function have Leukocyte Adhesion Deficiency III (LAD-III) in which
platelets are unable to activate αIIbβ3 and immune cells are unable to
activate β2 integrins resulting in both severe bleeding and impaired
4

immune function (7-10).

Both talins and kindlins contain phospholipid

binding domains, suggesting that their interactions with the inner leaflet
may play a role in the regulation of αIIbβ3.
Integrin “outside-in signaling” can refer to one of two processes.
The first is stabilization of an active integrin conformation by extracellular
ligands. The second refers to signaling events downstream of integrin
activation and ligand binding.

Generally, these events require integrin

oligomerization and involve recruitment of a number of signaling
molecules including Src-family kinases (SFKs) (23).

However, the

dynamics of the signaling complexes remains an area of active research.
Talin and kindlin are members of the membrane-binding FERM
(band 4.1/Ezrin/Radixin/Moesin) domain family. Their interactions with the
αIIbβ3 cytoplasmic domains are likely to occur simultaneously with binding
to the plasma membrane. Therefore, any equilibrium description of
integrin protein-protein interactions must include interactions with the inner
membrane leaflet. For simplicity, interactions between soluble proteins
and the inner leaflet can be divided into two categories. First, proteins can
bind using a combination of nonspecific electrostatic interactions with lipid
head

groups

and

hydrophobic

interactions

through

insertion

of

hydrophobic side chains (24, 25). Second, there are a host of domains
that differentiate between lipid head groups with a spectrum of specificity
(26). However, “non-specific” electrostatics are likely to play a role in even
“specific” head group recognition as lipid binding domains are often

5

positively charged and the inner leaflet of the plasma membrane is greater
than 20% negatively-charged phosphatidylserine (PS).
The majority of negatively-charged lipids reside on the inner leaflet
of the plasma membrane bilayer. PS is the most prevalent monovalent
anionic lipid in mammalian cells and platelets, representing greater than
20% of the inner leaflet (26). The distribution of PS is asymmetric and it is
actively transported from outer leaflet to the cytosolic face of the plasma
membrane. During apoptosis or platelet activation, PS redistributes such
that roughly half is on both the outer and inner leaflets. Exposed PS
serves as an inflammatory nidus and a site for the assembly of clotting
factor complexes.
The laboratories of Honig, McLaughlin, and Murray have developed
models for negatively charged bilayers containing monovalent lipids (27,
28). They found that the molar partition coefficient varies exponentially
with the percentage of PS (28, 29), i.e. the ∆G of association is linear with
percentage charged lipid concentration.

These experiments were

extended to the interaction of the myristoylated anchor of c-Src a kinase
involved in outside-integrin signaling. While the myristoyl tail produced
significant thermodynamic driving force for membrane association,
electrostatics increased the affinity significantly (29). Phosphoinositides
are negatively-charged lipids that exist in much lower concentrations than
phosphatidylserine, but are more dynamically regulated to produce local
concentrations of specific lipids to regulate signal transduction (26). As

6

they contain a number of phosphates, they are negatively-charged and
contribute a significant amount of electrostatic driving force to protein-lipid
interactions (24).

Their ability to support highly specific protein-lipid

interactions is dependent on the phosphate geometry at different locations
on the inositol ring and can be differentiated with surprising precision (26,
30).
Several lines of evidence suggest that PtdIns(4,5)P2, plays a
significant role in integrin regulation and the turnover of integrin complexes
(31) (32). Likewise, it has been suggested that an interaction between
talin-1 and PtdIns(4,5)P2 directly competes with autoinhibitory interactions
between the integrin binding FERM domain and its C-terminal rod domain
(33). The talin FERM domain binds directly to the C-terminus of
phosphatidylinositol-4-phosphate-5-kinase-γ (PIP5KIγ), a lipid kinase that
generates PtdIns(4,5)P2 from PtdIns(4)P, suggesting that talin may recruit
PtdIns(4,5)P2 to integrin signaling complexes.

However, PIP5KIγ

knockout cell lines continue to support inside-out integrin activation, but
exhibit loss of integrity under mechanical stress (34), suggesting that
PtdIns(4,5)P2 may recruit secondary signaling molecules or simply
reinforce talin-lipid interactions under mechanical shear.

7

Chapter 2 NMR analysis of the αIIb β3 cytoplasmic
interaction suggests a mechanism for integrin
regulation.
Abstract
The integrin αIIbβ3 is a transmembrane (TM) heterodimeric
adhesion receptor that exists in equilibrium between resting and active
ligand binding conformations. In resting αIIbβ3, the TM and cytoplasmic
domains of αIIb and β3 form a heterodimer that constrains αIIbβ3 in its
resting conformation.

To study the structure and dynamics of the

cytoplasmic domain heterodimer, we prepared a disulfide-stabilized
complex consisting of portions of the TM domains and the full cytoplasmic
domains. NMR and hydrogen-deuterium exchange of this complex in
micelles showed that the αIIb cytoplasmic domain is largely disordered,
but it interacts with and influences the conformation of the β3 cytoplasmic
domain. The β3 cytoplasmic domain consists of a stable proximal helix
contiguous with the TM helix and two distal amphiphilic helices.

To

confirm the NMR structure in a membrane-like environment, we studied
the β3 cytoplasmic domain tethered to phospholipid bilayers. Hydrogendeuterium

exchange

mass

spectrometry

and

circular

dichroism

spectroscopy demonstrated that the β3 cytoplasmic domain becomes
more ordered and helical under these conditions, consistent with our NMR
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results. Further, these experiments suggest that the two distal helices
associate with lipid bilayers, but undergo fluctuations that would allow
rapid binding of cytoplasmic proteins regulating integrin activation, such as
talin-1 and kindlin-3.

Thus, these results provide a framework for

understanding the kinetics and thermodynamics of protein interactions
involving integrin cytoplasmic domains and suggest that such interactions
may act in a concerted fashion to influence integrin stalk separation and
exposure of extracellular ligand binding sites.

I. Introduction
Integrins, ubiquitous heterodimeric adhesion receptors, reside on
cell surfaces in equilibrium between resting low-affinity and active highaffinity conformations. Interactions involving the transmembrane (TM) and
cytoplasmic domains of integrin α and β subunits maintain the low affinity
conformation, whereas intracellular signaling events disrupt these
interactions, resulting in global conformational changes that activate the
integrin (18). Following ligand binding, integrins cluster into complexes
that initiate intracellular signaling pathways (35).
On circulating platelets, the integrin αIIbβ3 is maintained in a
resting conformation until platelets encounter vascular damage where it is
rapidly shifted to its active conformation. This enables αIIbβ3 to mediate
platelet aggregation by binding soluble ligands such as fibrinogen and von
Willebrand factor (5). Activation occurs when intracellular proteins such as
talin-1 and kindlin-3 bind to conserved motifs in the β3 cytoplasmic
9

domain, thereby disrupting TM and cytoplasmic domain heterodimers (19).
It has been proposed that membrane-proximal αIIb and β3 cytoplasmic
domain sequences form an activation-constraining “clasp”, featuring a
salt-bridge between αIIb Arg995 and β3 Asp723 (36). However, studies
specifically designed to detect this salt bridge have failed to do so (37).
Although structures for the αIIbβ3 cytoplasmic domain heterodimer
have been determined using soluble peptides and NMR, they may not
reflect native contacts because they fail to account for constraining TM
interactions (38, 39). To investigate the structure and dynamics of the
cytoplasmic domain heterodimer as it exists in resting αIIbβ3, we
covalently trapped the complex by introducing an inter-subunit disulfide
bond near the C-terminal ends of the αIIb and β3 TM helices. The location
of the crosslink was based on a computational model of the αIIbβ3 TM
heterodimer (40). While this work was in progress, three structures for the
αIIbβ3 TM heterodimer plus short segments of the cytoplasmic domains
were reported, confirming the model used to guide the introduction of the
disulfide bond (15-17).
We used NMR and hydrogen-deuterium exchange (HDX) mass
spectrometry to study the structure and dynamics of the αIIbβ3
cytoplasmic domain heterodimer in micelles and phospholipid bilayers.
The αIIb cytoplasmic domain was largely disordered, but the β3
cytoplasmic domain consisted of a proximal helix contiguous with the TM
helix and two distal helices. The conformation of the proximal helix was
10

influenced by the presence of the αIIb cytoplasmic domain, whereas the
conformations of the distal helices were similar to those observed
previously in a monomeric protein corresponding to the β3 TM and
cytoplasmic regions (37). Further, the distal helices were amphiphilic and
likely lie along the inner surface of the platelet membrane. However, their
interaction with the membrane is not so stable as to impede rapid binding
of cytoplasmic proteins. Thus, our results provide a framework for
understanding the kinetic and thermodynamic coupling between the
cytoplasmic domains of integrins and intracellular signaling molecules,
interactions that act in a concerted fashion to induce cytoplasmic and TM
domain separation and the exposure of extracellular binding sites for
integrin ligands.

II. Results
Model αIIbβ
β3 cytoplasmic domain constructs.
Figure 2.1A and 2.1B shows the sequences of the αIIbβ3 TM and
cytoplasmic domains. Our laboratory’s previous structural studies of the
αIIbβ3 cytoplasmic domain focused on the lone β3 cytoplasmic domain in
the absence of αIIb (Figure 2.1C) (37).

Given that integrin activation

involves separation of the αIIb and β3 cytoplasmic domains, we reasoned
that the structure of this construct would mimic that of the active integrin
conformation. In order to understand how αIIb and β3 might interact with
each other in the inactive integrin state in which TM interactions place the

11

two cytoplasmic domains in close proximity, we designed a disulfide
cross-linked NMR construct (Figure 2.1D). Furthermore, to better under
stand how the membrane environment might participate in the structure
and dynamics of αIIbβ3, we designed two constructs for HDX analysis of
the active and inactive αIIbβ3 conformations in the presence of
phospholipid bilayers (Figure 2.1E and F).

Figure 2.1 The sequences of the αIIbβ
β3 TM and cytoplasmic domains
and experimental constructs used.
(A) The sequence of the β3 TM and cytoplasmic domains. (B) The
sequence of the αIIb TM and cytoplasmic domains. (C) The sequence of
the previously reported (37) NMR construct containing the β3 TM and
12

cytoplasmic domains spanning from residue 691 to 762. The N-terminus
contains a Gly-Ser-Ala that remains from the thrombin cleavage site. (D)
The sequence of the NMR construct containing the αIIbβ3 cytoplasmic
domains spanning from β3 residue 713 to 762 and αIIb residue 988 to
1008. The β3 sequence contains an N-terminal His-tag as well as a SerPro-Glu helical cap. The αIIb sequence contains an N-terminal Ser-ProGlu helical cap. (E) The sequence of the lipid-immobilized HDX construct
containing the β3 cytoplasmic domain spanning from residue 720 to 762.
It contains an N-termina Gly-Ser-His-Met-Gly from the thrombin cleavage
site and the NdeI restriction site. The β3 cytoplasmic domain was
covalently attached to maleimide-functionalized phosphatidylethanolamine
via a cysteine substitution at position 719. (F) The sequence of the bilayertethered αIIbβ3 HDX construct spanning β3 residues 720 to 762 and αIIb
residues 995 to 1008. The αIIbβ3 heterodimer contains a disulfide crosslink between β3 residue 719 and αIIb residue 954. The N-terminus of αIIb
is functionalized with a myristoyl group for membrane immobilization. {(C)
made by RHL; (D) made by DGM; (E) and (F) made by DTM}
Our NMR construct (Figure 2.1D) contained the complete αIIb and
β3 cytoplasmic domains plus a portion of their TM helices. The peptides
were crosslinked by a disulfide bond between Cys residues replacing
Met987 and Leu712 in the TM domains of αIIb and β3, respectively. The
position for the disulfide bond was based on a model of the resting αIIbβ3
TM heterodimer (41). Recently published NMR structural studies and
disulfide crosslinking experiments confirm that a disulfide bond can be
accommodated at this position with little change in backbone structure
(15-17). For NMR experiments, the αIIb and β3 peptides were labeled
biosynthetically with
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C and

15

N in E. coli and disulfide-crosslinked after

activating the β3 Cys with 2,2’-dithiobis(5-nitropyridine) (42). The resulting
disulfide-crosslinked

construct

migrated

as

a

single

species

in

polyacrylamide gels with an apparent molecular weight consistent with the

13

mass of the heterodimers. Following disulfide bond reduction, two
peptides were observed that migrated with lower apparent molecular
weights (Figure 2.2A).

Figure 2.2 The αIIbβ
β3 cytoplasmic domain heterodimer construct
before and after reducing its disulfide bond.
The αIIbβ3 cytoplasmic domain heterodimer construct before and after
disulfide reduction. (a) Coomassie stained SDS-PAGE of the NMR
construct. Lane A, molecular weight markers. Lane B, the disulfidecrosslinked construct. Lane C, the construct following disulfide bond
reduction.
Differences in band intensity reflect differences in the
molecular weights of αIIb and β3 peptides, the β3 peptide is three times
larger than αIIb per mole. (b) Circular dichroism (CD) spectra of the αIIbβ3
heterodimer before (solid line) and after reduction (dotted line).
{Performed by DGM.}

The NMR construct was not stable in the absence of detergents
and when transferred to phospholipid bilayers resulted in precipitation of
the mixture. We reasoned that the NMR construct might be unstable in
bilayers due to the incomplete TM domain, which would be unable to span
the bilayer. Therefore two new constructs were designed for studies in the
presence of phospholipids. The intention of these constructs was to mimic
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the αIIbβ3 cytoplasmic domain as it exited the bilayer. The first construct
was designed to model the active β3 cytoplasmic domain in the absence
of αIIb.

In a recent disulfide crosslinking study (15) that mapped the

interface between αIIb and β3 TM and membrane proximal regions,
residue Ile719 was found to be the first β3 cytoplasmic residue to be
accessible to chemical cross-linking, suggesting that it is accessible to the
cytosolic compartment and likely at the membrane/cytosol interface.
Ile719 was also predicted to be at the membrane/cytosol interface when
the β3 TM and membrane proximal regions were modeled using the E(z)
membrane insertion potential (43).

Based upon these findings, we

reasoned that residue 719 would be appropriate for covalent attachment
to the phospholipid headgroups.

To do so, we introduced a cysteine

residue, which was reacted with the surface of bilayers containing
maleimide-functionalized phosphatidylethanolamine (Figure 2.1E, top).
The β3 cytoplasmic domain reacted readily with the bilayers and after two
hours, only the immobilized construct was observed (Figure 2.3A).
As for our NMR experiments, a disulfide cross-linked αIIbβ3
construct was designed for HDX studies in the presence of bilayers.
Besides placing Ile719 at the membrane surface recent disulfide crosslinking studies (15) also found that position 719 was part of a helical
interface between αIIb and β3. In that study residue 719 readily formed a
disulfide bond with position 994 in αIIb. Using similar chemistry as for the
NMR construct, the β3 cytoplasmic domain was attached to αIIb
15

cytoplasmic domain via a disulfide bond between residues 719 and 994
respectively. As disulfide chemistry was used to form the heterodimer,
maleimide chemistry could not be used for immobilization on the
membrane surface. Instead, a myristoyl group was covalently attached to
the N-terminus of αIIb. The myristoylated αIIbβ3 construct was purified by
HPLC (Figure 2.3B).

Figure 2.3 Mass spectra of membrane tethered αIIbβ
β3 cytoplasmic
domains.
(A) The β3 cytoplasmic domain peptide (MW = 5680) containing an Nterminal cysteine residue was reacted with large unilamellar vesicles
(LUVs) for 1.5 hours at pH 6.8 producing the lipid conjugated β3
cytoplasmic domain (MW = 6592). MALDI-TOF mass spectrometry was
performed on the starting material (bottom, magenta), the reaction after 30
minutes (middle, green), and the reaction after 1.5 hours (top, blue). (B)
Myristoylated-αIIbβ3 heterodimer was prepared as described in the
methods, purified by HPLC, and subjected to MALDI-TOF mass
spectrometry. {Performed by DTM.}
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Association of the αIIb and β3 cytoplasmic domains influences
their conformation.
Due to the inclusion of TM domain residues, the heterodimeric
construct was insoluble in aqueous buffers and was studied in
dodecylphosphocholine (DPC) micelles, similar to our previous analysis of
the monomeric β3 TM and cytosolic regions (37). CD spectroscopy of the
disulfide-linked construct contained bands at 190, 208, and 222 nm
consistent with helical secondary structure (Figure 2.2B). Disulfide bond
reduction resulted in a decrease in the magnitude of the molar ellipticity at
222 nm, indicating that the disulfide-linked construct was more structured
than its component monomers.
The interface between αIIb and β3 was mapped by comparing

13

C

resonances of the disulfide-linked and monomeric peptides. Like the
monomeric β3 cytoplasmic domain (37), Cα resonances of the β3
cytoplasmic domain in the disulfide-linked construct were consistent with
the presence of three helices: a proximal helix contiguous with the β3 TM
domain (TMproxH) and two distal cytoplasmic helices (CytoH1 and
CytoH2) (Figure 2.4A). No differences were observed between the distal
helices of monomeric and disulfide-linked β3, but there were significant
differences in the residues that define the proximal helix. The largest
differences occurred at residues 720 through 724, eight to twelve residues
downstream from the disulfide bond (Figure 2.4B), implying that the
differences reflect αIIb and β3 interactions rather than local perturbations
caused by the disulfide bond itself. Further, the chemical shifts are
17

indicative of increased helical content, consistent with the increased
helical character in the CD spectrum following disulfide bond formation.
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Figure 2.4 Interaction between αIIb and β3 cytoplasmic domains.
(A) Cα chemical shifts define three helical regions of β3 in the disulfidelinked heterodimer. Differences between the Cα resonances in the αIIbβ3
heterodimer and β3 monomer are shown as bars above the graph. (B) 13C
HSQC spectra of aliphatic atoms in the αIIbβ3 heterodimer (blue/purple)
and the αIIb and β3 monomers (red and green). {Performed by DGM.}
The

13

C HSQC spectra of the disulfide-linked and reduced states

were compared in order to determine the interface between the α and β
chains (Figure 2.4B). The chemical shifts of the Lys716 and Ile719 side
chains changed when the disulfide bond was reduced, while no
differences were observed for neighboring residues, suggesting that
Lys716 and Ile719 interact directly with αIIb (further supporting the choice
of disulfide cross-link in Figure 2.1F). Thus, Lys716 and Ile719 define a
face of TMproxH that includes Asp723, a residue postulated to form a salt
bridge with αIIb Arg995 (36). Analysis of the Asp723 side chain neither
confirmed nor refuted its interaction with αIIb. We did not identify NOEs
between Arg995 guanidine protons and β3 sidechains. The Arg995
resonances were characteristic of a dynamic side chain and did not
change substantially when the disulfide bond was reduced. Further, NMR
spectra and HDX results suggest that Asp723 and Arg995 are highly
solvent-exposed. Thus, any acid/base interaction would appear to be
dynamic and partially screened under physiological salt conditions.
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Structure of the β3 cytoplasmic domain crosslinked to the αIIb
peptide
Three-dimensional structures were calculated for the αIIb and β3
cytoplasmic domains using intra- and interchain NOEs, HN-Hα Jcouplings, and statistical analysis of chemical shifts (Figure 2.5A). We
were unable to assign more than 5 strong NOEs between αIIb and β3,
precluding calculation of a high-resolution structure. Moreover, the intraamide 1H-15N HSQC peak heights for αIIb became progressively greater
from its N- to its C-terminus, implying that the αIIb cytoplasmic domain is
largely unstructured near its C-terminus (Figure 2.6A). Thus, we focused
on defining the structure of β3 in the presence of αIIb. A structure for β3
was computed using 16 long-range, 235 medium-range, 259 short-range,
and 202 intra NOE restraints, 84 dihedral angle restraints, and 24
hydrogen bonds (Table S2.1).
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Figure 2.5 The structure of the β 3 cytoplasmic domain.
(A) Twenty structures in the NMR ensemble, consisting of two regions
encompassing residues Leu713-Trp739 and Asp740-Thr762, were aligned
separately over well-ordered regions. Domains interacting with αIIb, talin1, kindlin-3, and c-Src are enclosed by dashed lines and side chains that
make up interfaces are depicted as sticks. The two β3 NPXY motifs are
colored magenta and the Src-binding RGT motif is colored cyan. (B) A
single residue hinge at Arg724 is stabilized by packing between residues
Ile721 and Phe727 (green) and an electrostatic interaction between
Arg724 (blue) and Glu726 (red). (C) The first cytosolic helix (residues
Glu726-Arg736) is stabilized by a network of complementary charged
residues. Positively charged residues are colored blue and negatively
charged residues red. {Structure solved by DGM.}
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The C-terminal ends of TMproxH and CytoH1 pack together in a
well-structured helix-turn-helix motif. Arg724 serves as a single-residue
hinge between the two helices, having φ/ψ angles in the β/PPII region of
the Ramachandran plot and producing a 100.5 ± 8.8° angle between the
two helices.

A series of interactions, including strong NOEs between

Phe727 and Ile721, as well as electrostatic interaction between Arg724
and Glu726, stabilize the turn (Figure 2.5B). CytoH1 itself is stabilized by
a highly favorable arrangement of 12 intra-helical electrostatic interactions
between residues i and i+3/4 (Figure 2.5C).
CytoH1 is followed by a flexible linker spanning residues 738-743.
CytoH2 is then initiated by Asn744, the first residue of an NPXY motif
consisting of residues Asn744-Tyr747 (44, 45). Although NPXY motifs are
often found in β-turns, they are also helix initiation sites (46). Indeed,
Asn744-Tyr747 adopts an identical conformation in a crystal structure of
the F2F3 domains of talin-1 fused to a portion of the β3 cytoplasmic
domain (pdb code 1MK7, chain A residues 744-747) (44).

Conformational flexibility of the αIIbβ
β3 cytoplasmic domains in
micelles
The dynamics of the cross-linked αIIb and β3 cytoplasmic domains in
DPC micelles were studied by measuring the intensity of intra-amide 1HN HSQC peaks (Figure 2.6A) (47, 48). αIIb residues Val990-Asn996 and
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β3 residues Leu713-Glu726, comprising the TM-proximal helices,
displayed similar peak intensities, indicating limited mobility and stable
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structures. β3 CytoH1 was somewhat more dynamic, while CytoH2
showed graded mobility, becoming increasingly less structured near its Cterminus.

As noted, 1H-15N HSQC peak intensities for αIIb became

progressively greater near its C-terminus, implying that the terminal region
of the αIIb cytoplasmic domain is largely unstructured. These findings
were confirmed by NMR measurements of amide proton exchange with
solvent deuterons (HDX, Figure 2.6B) (49). Indeed, H-15N HSQC spectra
of TMproxH were highly protected from HDX, while the distal helices
exchanged in a rapid time regime that was not amenable to NMR studies.
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Figure 2.6 Backbone dynamics of the αIIbβ
β3 cytoplasmic domain
heterodimer.
(A) Backbone dynamics were inferred from intra-amide 1H-15N HSQC
peak heights and were compared with the corresponding isolated
β3 construct (37). (B) 15N HSQC spectrum of the disulfide-linked complex
before and after HDX. The β3 backbone amides Ile714-Ile721 are
protected from HDX, suggesting they form stable hydrogen bonds in a
helix. Other helical regions exchange with deuterium on the minute timescale, suggesting they make excursions from helical conformations.
{Performed by DGM}
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Conformational flexibility of the αIIbβ
β3 cytoplasmic domain in
phospholipid bilayers.
Accordingly, we used mass spectrometry to measure HDX kinetics
for the distal helices in phospholipid bilayer vesicles, a condition more
closely resembling natural membranes than detergent micelles. This type
of experiment has been used to determine membrane protein structure
and measure unfolding rates (50, 51). We focused on the β3 segment
spanning residue Thr720 to the C-terminus, because, as discussed above,
this represents the portion of β3 accessible to the cytosolic compartment
and the full-length NMR construct was not stable in bilayers.

The

cytoplasmic domain was studied in aqueous solution as well as tethered to
preformed large unilamellar vesicles (LUVs). As with our NMR studies, β3
was probed in the presence and absence of αIIb in order to determine the
effects of αIIb on its structure.
CD spectroscopy revealed that when the β3 cytoplasmic domain
was covalently tethered to bilayers, the peptide’s α-helical content
increased and the random coil signature decreased (Figure 2.7), indicating
that the β3 cytoplasmic domain interacts with phospholipid bilayers. To
measure HDX, free and tethered β3 peptides were incubated in D2O buffer
for varying periods of time, after which amide deuterium exchange was
quenched at pH 2.5. The quenched peptides were injected onto an
immobilized pepsin column to generate fragments that were analyzed by
tandem LC/MS. Free β3 peptide exchanged rapidly with D2O (Figure 2.8,
red), indicating that its conformation was largely disordered, consistent
26

with CD results (Figure 2.7). When the β3 peptide was membrane-bound,
the most membrane proximal region, Thr720-Glu732, remained tethered
to the lipid after proteolysis and was not observed. However, we observed
two fragments that contained portions of CytoH1 and CytoH2. Both
fragments had two kinetically distinct classes of amides: one class had
unprotected amides that exchanged at a rate indicative of an unstructured
backbone; the second class exchanged with a protection factor on the
order of 102 to 103, indicative of a helix making occasional excursions to
less well-structured conformations that allow HDX.

The fragment

containing the C-terminus of CytoH1, the flexible loop, and the N-terminus
of CytoH2 (Glu733-Thr753) had approximately 8 protected amides (Figure
2.8A, green). The second fragment contained the C-terminus of CytoH2
(Asn756-Thr762) and had only one protected amide (Figure 2.8B, green).
These results confirmed the location of CytoH1, which was identified by
NMR, as well as the hierarchy of increasing disorder that progresses from
the N- to the C-terminus of the β3 cytoplasmic domain.
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Figure 2.7 Circular dichroism confirms that interactions with
phospholipids stabilizes a helical conformation.
CD spectra were taken of free β3 in the absence of lipid (black dots),
membrane- tethered β3 (solid line), and β3 mixed with lipids, but not
reacted with the maleimide head group (grey dots and lines). CD spectra
of β3 alone were taken of 30 µM β3 in 25 mM phosphate 100 mM NaCl,
pH 6.8. For lipid conjugated β3, 15 µM β3 was conjugated to 1 mM total
lipid containing 20% POPG, 12% maleimide-PE, and 68% POPC in 25
mM phosphate with 100 mM NaCl, pH 6.8. Unconjugated β3 in the
presence of lipid contained 15 µM β3 and 1mM total lipid containing 20%
POPG and 80% POPC. {Spectra are representative of three independent
experiments. Performed by DTM]
Our NMR results suggest that when αIIb is held in close proximity
to β3 – as would be expected in the inactive αIIbβ3 conformation – a kink
is stabilized in β3. We hypothesized that such a kink would project distal
β3 cytoplasmic elements such as CytoH1 and CytoH2 parallel to the
membrane and encourage their interactions with the bilayer beyond the
interactions observed with lipid-immobilized β3. We therefore sought to
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determine by HDX whether this kink in the presence of bilayers might
stabilize distal structures observed by NMR.

As described above, we

synthesized and purified a disulfide cross-linked αIIbβ3 construct with an
N-terminal myristoyl membrane anchor.

This peptide was not water

soluble, but was readily solubilized when extruded with phospholipid
bilayers.

When HDX experiments were performed on this αIIbβ3

construct, similar pepsin cleavage products were observed. Again, the Nterminus was not seen, because of its covalent attachment to αIIb, but
peptides containing residues Glu733-Thr753 and the Asn756-Thr762 were
observed. Like β3 in the absence of αIIb (Figure 2.8A, green), the peptide
spanning Glu733-Thr753 was found to have approximately 8 protected
amides in the presence of bilayers (Figure 2.8A, blue). The protection
pattern for the most distal fragment was quite different, though.

The

peptide containing Asn756-Thr762 was found to be significantly protected
from exchange.

In the presence of bilayers, the heterodimeric αIIbβ3

cytoplasmic domain had 3-4 amides with protection factors on the order of
102-103 (Figure 2.8B, blue). These results support the NMR-based model
that the presence of αIIb stabilizes the interaction between β3 and the
membrane. It is possible that the protection of the distal β3 segment from
HDX could arise from direct interactions with αIIb and as opposed to a
helical interaction with the membrane, however, NOEs between αIIb and
the β3 segment were not observed in the NMR.
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Figure 2.8 HDX-MS of the αIIbβ
β 3 cytoplasmic domain in phospholipid
bilayers.
Model αIIbβ3 cytoplasmic domain constructs were prepared in pH 6.8
phosphate with 100 mM NaCl. Each sample was diluted 1:10 in pH 6.8
phosphate with 100 mM NaCl containing 90% D2O on ice. Deuteration
was quenched at pH 2.5 on ice and samples were injected onto a pepsin
column in tandem with LC-MS to resolve fragments and calculate
deuteration. The deuteration reaction for each sample was fit to a double
exponential rate equation assuming subpopulations of rapidly and slowly
exchanging amides. Peptide fragments containing (A) Glu733-Thr753 and
(B) Asn756-Thr762 were observed. For each peptide a theoretical curve
based upon the predicted intrinsic exchange rate for a disordered peptide
was generated (black). HDX was performed on free β3 cytoplasmic
domain (red), the β3 cytoplasmic domain covalently immobilized on
phospholipid bilayers containing 20% POPG, 12% maleimide-PE, and
68% POPC (green) which is predicted to model the active β3 state, and
disulfide cross-linked αIIbβ3 in phospholipid bilayers containing 20%
POPG and 80% POPC (blue) which is predicted to model the inactive
state. Residues highlighted in blue are predicted to be protected from
exchange based upon the NMR structure. Residues highlighted in orange
correspond to regions found to be disorganized in the NMR structure or at
the N-termini of helices and not predicted to be protected from exchange.
{Experiments performed once by DTM}
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The increased helicity of the β3 cytoplasmic domain (Figure 2.7) in
the presence of bilayers and its protection from HDX under these
conditions suggest that it interacts with the membrane surface. We used
E(z), a depth-dependent potential (43), to assess the binding of the β3
helices in membranes. As expected, TMproxH was predicted to partition
into the bilayer perpendicular to the membrane as an extension of the TM
helix, whereas CytoH1 and CytoH2 were predicted to lie along the
membrane surface, stabilized by hydrophobic residues Phe727 and
Phe730 in CytoH1 and Leu746, Tyr747, Ala750, Phe754, and Ile757 in
CytoH2 (Figure 2.9A).

III. Discussion
We have studied the structure and dynamics of the platelet integrin
αIIbβ3 cytoplasmic domain. We found the αIIb cytoplasmic domain
intrinsically disordered, consistent with its paucity of hydrophobic residues
and a recent NMR study using phospholipids bicelles (52). Nonetheless,
chemical shift perturbations indicate that αIIb interacts with the TM
proximal portion of β3 over the length of 12 residues, implying that αIIb
has a conformational bias toward structures that interact with β3. This type
of intrinsically disordered interaction has been found in proteins that
couple multiple signaling events to an overall equilibrium (53). In the case
of αIIbβ3, an intrinsically disordered interface would allow the integrin to
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rapidly shift between resting and active conformations following a breach
in vascular integrity.
The N-terminal portion of the β3 cytoplasmic domain consists of a
highly stable helix contiguous with the C-terminal end of the TM helix and
separated from a second surface-associated helix by a single-residue
hinge at Arg724. The remainder of the cytoplasmic domain consists of a
short unstructured region, a second cytoplasmic helix and a flexible Cterminal tail. CytoH1 and CytoH2 are likely stabilized by interactions with
the membrane bilayer (Figure 2.9A), although they are not so stable as to
lock the cytoplasmic domain into a single fixed conformation. Instead,
CytoH1 and CytoH2 undergo frequent excursions into non-helical
conformations within the aqueous environment. The association of CytoH1
and CytoH2 with membranes is consistent with previous NMR
experiments observing NOEs between micellar DPC and Trp739/Tyr747
(54). Amphiphilic domains proximal to TM domains have also been
detected in proteins such as voltage gated channels (55, 56),
phospholamban (57), and the influenza M2 proton channel (58, 59). The
association of cytoplasmic helices with membranes can change in
response to gating ligands or post-translational modification. For example,
the cytoplasmic helix of the pH-activated M2 channel changes its
orientation in response to pH. Also, aromatic residues in the cytoplasmic
domain of the T-cell receptor CD3ε subunit were found to insert into
membranes, including a tyrosine in its NPXY motif (60). Following T-cell
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receptor activation, the amphiphilic domain is released from the
membrane.

33

34

Figure 2.9 A linked equilibrium describing the activation of αIIbβ
β3 by
intracellular signaling molecules.
(A) The E(z) membrane insertion potential was used to model the
interaction of β3 with the membrane. It predicts that aromatic residues
(green) on one face of CytoH1 and CytoH2 will preferentially bind the
membrane. (B) The dynamic nature of the β3 cytoplasmic domain makes
protein-protein interaction motifs accessible. Dissociation of αIIb and
extension of the β3 TM-proximal helix to join CytoH1 allows talin-1 to bind
and places positively-charged residues on talin-1’s upper surface in a
favorable position to interact electrostatically with the inner membrane
leaflet. β3 is also now available to bind kindlin. Residues that are
perturbed by the αIIb cytoplasmic domain are shown in red. (C) An
equilibrium model of talin-1 and kindlin-3 binding the integrin cytoplasmic
domain. To the left is a resting conformation with helices CytoH1 and
CytoH2 interacting with the bilayer. The fully inactive state is not
competent to bind talin-1 or kindlin-3 because the membrane obstructs
access to β3. To the right is a fully active conformation with separated TM
and cytoplasmic domains. In between exists an ensemble of states in
which the integrin is not active, but the β3 cytoplasmic domain samples a
wide range of conformations and is accessible to intracellular molecules.
Although talin-1 and kindlin-3 can bind the ensemble of free cytoplasmic
domains in the middle column, available data are insufficient to predict the
order of binding. Therefore, equilibria depicting talin-1 binding first (top)
and kindlin-3 binding first (bottom) are shown. However the fact that both
kindlin-3 and talin-1 are necessary for activation suggests that both bind to
the integrin cytoplasmic domain.

The marginally stable interactions between the membrane bilayer
and the β3 cytoplasmic helices are likely important for allowing kinetic
access to cytoplasmic proteins, such as talin-1 and kindlin-3, responsible
for triggering αIIbβ3 activation (19). The structure of β3 elucidated here
presumably represents the resting state which must undergo structural
changes to allow binding of these proteins. The talin-1 binding site,
extending from the C-terminus of the TM helix through CytoH1 to the
NPxY motif near the N-terminus of CytoH2, is masked in the NMR
structure by interactions with the αIIb tail and the phospholipid bilayer.
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Interaction with membranes is facilitated by the bend between TMproxH
and CytoH1 at Arg724; if this residue instead continues the TMproxH αhelix (Figure 2.9B), CytoH1 becomes an extension of the TM helix,
allowing binding of the talin-1 head domain (61, 62). This orientation not
only allows interaction of the talin-1 F3 domain with the β3 tail, but also
electrostatic interactions between acidic lipids on the cytoplasmic leaflet of
the bilayer and positively charged residues in talin-1’s F2 and F3 domains.
Moreover, the interaction of the β3 tail with talin-1 removes the C-terminal
region of β3 from the membrane and positions its kindlin-binding site for
simultaneous interaction with kindlin-3. Such a tandem interaction has
recently been demonstrated for dimerization of the PTB domain of the
cytoplasmic adaptor protein Dok7 (63). Displacement of this segment from
the membrane also destabilizes the C-terminal β3 helix, allowing it to more
easily conform to the requirements for kindlin-3 binding.
The interactions of talin-1 and kindlin-3 with β3 show the hallmarks
of a cooperative system; association of either protein with its β3 binding
site occurs at the thermodynamic expense of disrupting favorable β3membrane binding interactions. Moreover, binding of one protein primes
the system for a more favorable interaction with the second. Thus, the
sites are both kinetically and thermodynamically linked, as shown in
Figure 2.9C. The talin-1 binding event is likely the key step in tail
separation, given the proximity of the talin-1 interacting site to the αIIbβ3
interface. Thus, at sufficiently high talin-1 concentrations, it should be
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possible to activate αIIbβ3, even in the absence of kindlin-3 (64).
However, under physiologic conditions, our model predicts that kindlin-3
also plays a pivotal role for interaction of talin-1 with the β3 tail. At present,
it is unclear whether there is a preferred temporal sequence for binding of
kindlin-3 versus talin-1 during physiological αIIbβ3 activation. However,
the greater mobility of the kindlin-3 binding site in the β3 cytoplasmic
domain suggests it might have a kinetic advantage over talin-1, assuming
both are present in appropriate forms for binding. Figure 2.9C (top and
bottom) illustrates both kinetic possibilities for the initial binding step. Once
initial binding occurs, subsequent interactions and conformational changes
become increasingly favorable, ultimately tipping the equilibrium towards
tail separation and αIIbβ3 activation (Figure 2.9C, middle panel). This
thermodynamic coupling model could be extended to any number of
cytoplasmic events playing negative or positive roles in activation. We
predict that direct interactions of the β3 cytoplasmic domain with αIIb and
the phospholipid bilayer help restrain αIIbβ3 in a resting state. Any protein
that binds more tightly to the separated cytoplasmic domains than the
cytoplasmic

domain

heterodimer

will

have

an

activating

effect.

Furthermore, proteins that negatively impact talin-1 binding will have an
inhibitory effect on αIIbβ3 activation.

IV. Methods
Plasmid Constructs—A cDNA encoding αIIb residues Trp988Glu1008 was cloned into the vector pET-16b (Novagen) as a C-terminal
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fusion with the designed protein α3D (65). The region between the αIIb
sequence and α3D included a proline to disrupt secondary structure, two
glycines as a flexible spacer, a thrombin cleavage site, an SPE N-terminal
helix cap, and a cysteine for crosslinking to the β3 peptide. The αIIb
peptide

sequence

α3D-P-GG-LVPR-SPE-C-

was:

WKVGFFKRNRPPLEEDDEEGE. A cDNA encoding β3 residues Leu713Thr761 was cloned into the vector pET-15b (Novagen) downstream from a
polyhistidine tag. The construct included an SPE N-terminal helix cap
followed by a cysteine for crosslinking. The β3 peptide sequence was:
MGSSHHHHHHSSGLVPRGSHM-SPE-CLIWKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT.
The fidelity of the constructs was confirmed by DNA sequencing.
A

β3

shortened

cytoplasmic

domain

(MGSSHHHHHHSSGLVPRGS-|-H
MG-C-TIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT)
was cloned into the pet-28a vector. It contained a cysteine for reaction
with phospholipid bilayers or αIIb.
Protein Expression and Purification—The α3D-αIIb fusion protein
and the His-tagged β3 protein were expressed in E. coli strain BL21 and
labeled biosynthetically with

13

C glucose and/or

15

N ammonium chloride

The α3D-αIIb fusion protein was

(Cambridge Isotope Laboratories).

isolated from the supernatant of bacterial lysates, cleaved with thrombin,
and purified by reverse-phase HPLC.
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The His-tagged β3 protein was

isolated on Ni-NTA resin using the QIAExpressionist protocol for
denaturing conditions (Qiagen) and purified by reverse-phase HPLC.
These protocols generated >10 mg of the αIIb and β3 proteins per liter
culture. The molecular weight of each product was confirmed by mass
spectroscopy.
The His-β3 construct used for HDX was expressed in BL21-DE3 E.
coli and purified using Ni-NTA chromatography on an Akta FPLC (General
Electric Healthcare). Purified His-β3 was dialyzed into 50mM Tris, 100
mM NaCl, pH 7.5 and cleaved with thrombin overnight at room
temperature.

The

resulting

peptide

(GSHMG-C-

TIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT)

was

purified by reverse phase HPLC on a C4 preparative column (Vydac) on a
water/acetonitile/iPrOH gradient in 0.1% TFA.

SDS-PAGE of αIIbβ 3 NMR construct-The disulfide cross-linked
heterodimer was dissolved in LDS loading buffer and run on a NUPAGE
SDS-PAGE gel. Excess TCEP was added to an identical sample and run
in an adjacent lane. The gel was washed and stained with Coomassie
GelCode stain (Pierce).

Synthesis of the myristoylated αIIb cytoplasmic domain–αIIb-CT
was synthesized on Wang resin preloaded with an Asp residue using a
Symphony peptide synthesizer at 0.1 mM scale in 25% DMSO/75% NMP
39

with Fmoc-chemistry. αIIb-CT was myristoylated on resin by reacting the
protected peptide with 5-fold excess HBTU activated myristic acid (Sigma)
for three hours at room temperature. αIIb-CT was cleaved from the resin
TFA/triethylsilane/water (95/2.5/2.5 v/v) for three hours and precipitated
into dry-ice cold diethylether. β3-NITYRGT was purified by reverse phase
HPLC (Varian Prostar) using a C4 preparative column (Vydac) on a
water/acetonitrile/iPrOH gradient with 0.1% TFA.
Formation

of

a

disulfide-linked

αIIbβ 3 cytoplasmic domain

heterodimer for NMR—The β3 peptide was dissolved at 5 mg/ml in 50 mM
MES buffer, pH 6.0, containing 2M guanidine, after which its cysteine thiol
was activated with a 5-fold molar excess of 2-2'dithio-bis-(5-nitropyridine)
dissolved in DMSO (42). After excess 2-2'dithio-bis-(5-nitropyridine) was
removed on a PD-10 column (GE Healthcare), the activated β3 was
reacted with a slight molar excess of the αIIb protein in guanidine-MES
buffer, pH 6.5. Disulfide-linked αIIbβ3 was purified using reverse phase
HPLC in a gradient with 60% iPrOH, 30% ACN, 10% H2O with 0.1% TFA.
Its molecular weight confirmed by mass spectrometry.
Preparation

of

a

disulfide-linked

membrane-tethered

αIIbβ3

cytoplasmic domain heterodimer for HDX. The β3 cytoplasmic domain
was prepared as described earlier. To form the myristoylated αIIbβ3
heterodimer, the β3 cytoplasmic domain was reacted with 2-2'dithio-bis-(5nitropyridine) in 50% acetic acid to produce activated 2-thio-(5-
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nitropyridine) adduct, which was transferred to pH 5 sodium acetate buffer
and separated from unreacted 2-2'dithio-bis-(5-nitropyridine) by passage
over a PD-10 buffer exchange column (GE Healthcare). The activated β3
was diluted nine fold with acetonitrile and reacted with a slight excess of
Myr-αIIb. It was crucial to perform this reaction in an organic solvent, as
Myr-αIIb homodimers were the primary product in aqueous buffers, likely
due to formation of micelles or aggregates due to the myristic functional
group that produced a high local concentration of Myr-αIIb thiol that
displaced β3 from the αIIbβ3 heterodimer. The reaction was diluted with
pH 2 water and immediately frozen and lyophilized for purification by
reverse phase HPLC on a gradient with 60% iPrOH, 30% ACN, 10% H2O
with 0.1% TFA.
Preparation

of

membrane tethered β3. Lyophilized Cys-β3

construct was lyophilized and re-dissolved in bilayer conjugation buffer
(25mM sodium phosphate or MOPS, 100 mM NaCl, pH 6.8).

Large

unilamelar vesicles (LUVs) were generated by evaporating a mixture of
20% 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (POPG,
Avanti Polar Lipids), 4 fold molar excess of 1,2-dipalmitoyl-sn-glycero-3phosphoethanolamine-N-[4-(p-maleimidomethyl)cyclohexanecarboxamide] (16:0 PE MCC, Avanti Polar Lipids) relative to β3 peptide,
and

1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine

(POPC,

Avanti

Polar Lipids) to a thin film under nitrogen and re-suspending the dried
lipids in the bilayer conjugation buffer. LUVs were prepared by extruding
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20 times through a 0.1 µm filter (Avanti Polar Lipids). β3 peptide was
reacted with 4 fold molar excess 16:0 10 PE MCC.

The conjugation

reaction was performed at pH 6.8 to minimize lysine amine-maleimide side
reaction which is strongly disfavored at below pH 7.
NMR Spectroscopy—Purified, disulfide-linked αIIbβ3 heterodimer
was dissolved at 1 mM in 5 mM sodium phosphate buffer, pH 6.0,
containing 100 mM perdeuterated DPC (Cambridge Isotope Laboratories),
10% deuterium oxide, and 0.02% sodium azide. Samples were analyzed
at 37ºC on a 750 MHz NMR spectrophotometer equipped with a Varian
probe (66).
CD spectroscopy for the NMR sample—CD spectra of 10 µM
disulfide-linked αIIbβ3 heterodimer in 5 mM sodium phosphate buffer, pH
6.5, containing 10mM dodecylphosphocholine (DPC) were collected on a
JASCO J-810 spectropolarimeter with a path length of 1 mm before and
after the addition of a 5-fold molar excess of the reducing agent tris(2carboxyethyl) phosphine hydrochloride (Sigma-Aldrich). Measurements
were made stepwise for each 1 nm between 190 nm to 260 nm and
averaged over ten scans.
Assignment of chemical shifts—The backbone, aliphatic, and
aromatic resonances in the αIIb and β3 subunits were assigned using a
standard

battery

of

experiments.(66)

Complete

residue-specific

assignments for the Hα, N, Cα, and Cβ resonances in β3 were obtained
using the HNCACB(67) and CBCA(CO)NH(68) experiments.
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Carbonyl

carbons were assigned from HNCO experiments.(69) Aliphatic protons
and

carbons

were

identified

using

H(CCCO)NH,(70,

71)

(H)CC(CO)NH,(70, 72, 73) and H(C)CH-TOCSY(74-77) experiments.
Pro-chiral leucine and valine methyls were distinguished in the

13

C-

coupled carbon HSQC of a metabolically labeled sample expressed in
13

media containing 10%

C glucose.(78)

Aromatic resonances were

assigned using HBCBCGCDHD and HBCBCGCDCEHE experiments,(79)
an aromatic carbon HSQC, an aromatic
NOESY experiments.

13

C-edited NOESY, and other

Assignments for αIIb residues 988-1000 were

completed using the same strategy. Additionally, resonances in the αIIb
acidic tail E1001EDDEEGE1008 were identified, but were not useful for
structural analysis due to spectral overlap. Proton chemical shifts were
referenced to residual water signal, while 13C and 15N chemical shifts were
indirectly

referenced.

Chemical

shifts

were

deposited

in

the

BioMagResBank (80).
Identification of NOEs—Nuclear Overhauser Effect restraints
(NOEs) were obtained from an 15N-editied NOESY, an aliphatic
NOESY, an aromatic

13

C-edited NOESY, and a 4D

13

C-edited

13

C-edited

NOESY.(81, 82) Mixing times were optimized for different NOESYs and
ranged from 80 ms in the

13

C-edited NOESYs to 100 ms in the

15

N-editied

NOESY. The solvent contained 99% D2O in the 4D NOESY.
HN-Hα J-coupling—Phi dihedral angle restraints were obtained
from HN-Hα J-couplings measured in the HNHA experiment.(81)
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Phi

angles were calculated using the Karplus equation with coefficients A =
6.51, B = -1.76, and C = 1.60.

β3 residues Lys716-Thr720, Phe727-

Arg736, and Leu746-Asn756 were given helical phi restraints based on
chemical shift analyses, NOE patterns, and HDX experiments that suggest
they reside in helices. Other residues were given J-coupling restraints
that restrict the phi dihedral to 1-4 possible angles.
Hydrogen-deuterium exchange (HDX)— HDX was performed by
lyophilizing a NMR sample and re-dissolving it in deuterium oxide.
Exchange was monitored in the HSQC experiment and the first time-point
was taken at 11 minutes.
Residual dipolar couplings (RDCs)— RDCs were obtained for
samples aligned in axially stretched polyacrylamide gels. A dried, 6mm
diameter, 5.5% polyacrylamide gel was soaked with an NMR sample for
72 hours, then funneled into a 4.2mm diameter NMR tube.(83) Cα-C’
RDCs were obtained using a Cα-coupled HNCO experiment.(69)
Implementation of distance restraints—Distance restraints were
derived from NOE experiments and HDX. NOESY cross-peak volumes
were converted to upper distance limits by the program CALIBA of the
CYANA package (84). NOE peaks were divided into three classes with
different calibration functions and constants: a 1/r6 dependence was used
for

backbone-proton-backbone-proton

NOE

values,

and

a

1/

r4

dependence for NOEs involving side-chain protons and methyl groups.
The upper and lower cutoffs for NOEs before application of pseudoatom
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corrections were set as 2.4 and 6.0 Å for strong and weak NOEs,
respectively. During the structure calculation and NOE assignment, the
calibration curves were refined iteratively based on plots of cross-peak
volumes versus average proton-proton distances in the current structures.
For each distance constraint, the lower limit was set as 1.8 Å, which
corresponds to two hydrogen van der Waals radii.

Additionally, 24

hydrogen bonds were used for the regular secondary elements Glu711Asp723, Glu726-Ala736, and Pro745-Ile758. 5 hydrogen bond restraints,
which were also confirmed from HDX, were implemented by setting the N
to i+4 O distance to 3.0 Å with 10% error, while the remaining hydrogen
bond restraints were held with 20% error.
Implementation of angle restraints—Dihedral angle restraints were
derived from TALOS+(85) (86) and J-coupling experiments.(81)

The

TALOS algorithm predicts backbone phi and psi angles based on protein
sequence and assigned resonances from a database of known structures.
TALOS-derived phi and psi dihedral restraints were used for β3 residues
Cys712 - Thr758, except for residues Arg724, Lys738 and Trp739, which
were predicted to be helical with high confidence, consistent with NOE
patterns, HDX, and J-coupling. Additionally, phi dihedral angle restraints
were obtained from HN-Hα J-couplings.

β3 residues Leu713-Asp723,

Glu726-Arg736, and Pro745-Thr758 were given helical phi and psi angle
restraints based on chemical shift analysis, NOE patterns, and HDX
experiments which suggest they reside in helices. Other residues were
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given J-coupling restraints that restrict the phi dihedral to 1-4 possible
angles.(81)
Implementation of RDC restraints—RDCs were measured and
evaluated. Nonetheless, the dynamics of the αIIbβ3 construct prevented
fruitful refinement of the structural ensemble using RDCs.
Structure Calculation—Data were processed with FELIX, analyzed
with Sparky and Xeasy (87) , and structures were calculated using
CYANA (84) and finally refined by XPLOR-NIH.(88) Structure calculations
and refinement algorithms were based on the anneal.py and refine.py
example scripts that come with the XPLOR-NIH package. Structures were
calculated for the β3 portion of the disulfide linked αIIb/β3 construct
consisting of the SPE N-terminal helix cap, the cysteine used to form the
disulfide crosslink, and β3 residues 713-762:
SPE-CLIWKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT
where the italicized residues were engineered and the rest of the construct
corresponds to the β3 cytosolic domain.

Each algorithm included an

initial, high temperature simulated annealing cycle followed by a longer
simulated annealing cycle with both cycles restricted to torsional
movements.

After

the

simulated

annealing

cycles,

the

output

conformation was minimized in both torsional and Cartesian space. The
energy function included a repulsive van der Waals term and potentials
that enforced bond lengths, bond angles, and improper angles.
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Additionally, the refinement algorithm included a potential that enforced
backbone geometries that are consistent with Ramachandran space.
Other potentials enforced NMR restraints as described below.
No violations >0.5 Å per conformer were observed. The statistics of the
structure determination are summarized in Table S2.1 and show that a
high-resolution and high-quality structure was obtained. The final structure
was deposited in the PDB(89) (accession code: 2KV9).
Calculation of a structural ensemble for the β 3 cytoplasmic
domain—NOE distance restraints were derived from a 3D
NOESY, 3D aliphatic
and a 4D

13

C-edited NOESY, 3D aromatic

15

N-edited

13

C-edited NOESY,

13

C-edited NOESY (75). Hydrogen bonding distances and

geometry restraints (90) were implemented for the backbone amides of
the β3 regions Glu711-Asp723, Glu726-Ala736, and Pro745-Ile758,
predicted to reside in α-helices based upon NOEs and TALOS+. The φ
and ψ dihedrals of β3 residues Cys712-Thr758 (excluding Arg724, Lys738
and Trp739) were restrained based on a statistical analysis of chemical
shifts using the TALOS+ algorithm (85). Structures were calculated using
CYANA (84) and refined with XPLOR-NIH using a protocol similar to the
anneal.py and refine.py example scripts that come with the software
package (88, 91). A summary of the structural restraints is reported in
Table S2.1.
Circular Dichroism (CD) spectroscopy of lipid-conjugated β3. CD
spectra were taken on a JASCO J-810 spectropolarimeter. 15 µM β3 was
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conjugated to 1 mM total lipid and probed in 25 mM phosphate with 100
mM NaCl, pH 6.8.

Spectra of free β3 were obtained of 30 µM β3.

Measurements were made stepwise for each 1 nm between 200 nm to
240 nm and averaged over three scans.
Pepsin-LC-MS/MS HDX. A stock solution consisted of 15 µM β3
peptide or β3 peptide conjugated to lipid in 25 mM phosphate and 100 mM
NaCl, pH 6.8. H-to-D exchange was initiated by diluting 5 or 10 µL of
peptide stock solution into 15 or 10 µL of deuterated buffer, respectively.
The reaction mixtures were then incubated for 10 seconds to 1.4 hours, as
were non-deuterated control samples. Peptides fragments were collected
on a reverse phase trap column (4 µL bed volume, ExSAR) for 3 min.
Peptide

fragments

were

eluted

from

the

trap

and

separated

chromatographically on a reverse phase column (4 µL bed volume,
ExSAR) using a linear HPLC gradient of 12% to 45% acetonitrile over 11
minutes (pH 2.5, 0°C) at a 6 µL/min flow rate.

Peptides were ionized by

ESI for mass spectrometric analysis in a Thermo Fisher OrbiTrap-LTQ.
Resulting mass spectra were analyzed using the DXMS software
package (Sierra Analytics).

The deuterium values per peptide were

corrected for the deuterium content in the reaction conditions, as well as
for deuterium loss in liquid handling by assuming an average of 75%
deuterium recovery.
HXpep (92).

Intrinsic exchange curves were generated using

Experimental curves were generated from the exchange

rates generated by exponential fitting of intrinsic curves. Fitting of the
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experimental curves gives the slowing factor, which is a measure of the Hto-D exchange protection when compared to a random coil structure.

Supplemental

Table S2.2.1 Summary of β3 structure statistics
Conformationally restricting distance constraints
Intraresidue [i = j]
Sequential [|i – j| = 1]
Medium Range [1 < |i – j| < 5]
Long Range [|i – j| => 5]
Total
Dihedral angle constraints
ϕ
ψ
Hydrogen bond restraints
Average number of constraints per residue
Average number of distance constraints violations per
Xplor-NIH conformer
> 0.5 Å
Average number of dihedral-angle constraint violations
Xplor-NIH conformer
> 5°
Average r.m.s.d. to the mean coordinates [Å]
Residues 713-723 and 726-736, backbone heavy
atoms
Residues 713-723 and 726-736, all heavy atoms
Residues 713-723,726-736 and 745-758 , backbone
heavy atoms
Residues 713-723,726-736 and 745-758, all heavy
atoms
PROCHECK(93) G-factors Z-score for all residues (ϕ and
ψ / all dihedral angles) a
PROCHECK(93) G-factors Z-score for ordered residues (ϕ
and ψ / all dihedral angles) b
MOLPROBITY(94) clash Z-score
(all residues a / ordered residues b)
Ramachandran plot summary [%] (all residues a / ordered
residues b)
most favored regions
Additionally allowed regions
generously allowed regions
disallowed regions
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202
259
235
16
712
42
42
24
15.2

0

0
0.68 ± 0.25
1.56 ± 0.27
4.63 ± 1.37
5.27 ± 1.46
2.08 / 1.89
2.68 / 2.60
-1.18 / -1.18

90.8 / 94.5
7.8 / 5.2
1.1 / 0.3
0.3 / 0.0

a
b

Residues 709 - 762
Residues 711-735, 738-758
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Chapter 3 The affinity of talin-1 for the β3-integrin
cytosolic domain is determined by its phospholipid
bilayer environment.
Abstract
Binding of the talin-1 FERM domain to the β3 cytosolic tail causes
activation of the integrin αIIbβ3. The FERM domain also binds to acidic
phospholipids. Although much is known about the interaction of talin-1
with integrins and lipids, the relative contribution of each interaction to
integrin regulation and possible synergy between them remain to be
clarified. Here, we examined the thermodynamic interplay between FERM
domain binding to phospholipid bilayers and to its binding sites in the β3
tail. We found that although both the F0F1 and F2F3 subdomains of the
talin-1 FERM domain bind acidic bilayers, the full-length FERM domain
bound with an affinity similar to F2F3, indicating that F0F1 does not
significantly increase the affinity for the membrane. When free in solution,
the β3 tail has weak affinity for the FERM domain. However, appending
the tail to acidic phospholipids increased its affinity for the FERM domain
by three orders of magnitude. Nonetheless, the affinity of the FERM for
the appended tail was similar to its affinity for binding to bilayers alone.
Thus, talin-1 binding to the β3 tail is a ternary interaction dominated by a
favorable surface interaction with phospholipid bilayers and set by lipid
composition. Nonetheless, interactions between the FERM domain, the β3
tail, and lipid bilayers were not optimized for a high-affinity synergistic
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interaction, even at the membrane surface. Instead, the interactions
appeared to be tuned in such a way that the equilibrium between inactive
and active integrin conformations can be readily regulated.

I. Introduction
The integrin αIIbβ3 resides on the platelet surface in equilibrium
between resting and active conformations (5, 6, 95-97). On circulating
platelets, αIIbβ3 is constrained in its inactive conformation to prevent
spontaneous platelet aggregation. Similarly, the cytoskeletal protein talin1, whose binding to the β3 cytosolic tail (CT) stabilizes the active
conformation of αIIbβ3 (98-100), is sequestered away from the β3 CT
(101). Besides interacting with integrins, talin-1 interacts with negativelycharged phospholipids (102-104) and phosphoinositides (31, 33, 105,
106). Stimuli generated at sites of vascular damage recruit talin-1 to the
platelet plasma membrane, thereby promoting αIIbβ3 activation (12, 19).
Much is known about the interaction of talin-1 with integrins and lipids, but
the relative contribution of each interaction to integrin regulation and
possible synergy between them remain to be clarified. Elucidating these
interactions is important for understanding events leading to and
controlling the formation of integrin complexes and for potential
pharmacologic modulation of integrin signaling.
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Talin-1 is a 250 kD protein containing a 45 kD N-terminal head
domain attached via a flexible linker to a 200 kD C-terminal rod domain
(99). Because the head domain is packed against the rod domain in its
inactive state (107), talin-1 recruitment to the membrane and to integrin
β CTs requires disruption of this interaction (108). At integrin-mediated
cellular adhesions, the orientation of talin-1 is highly polarized, with its
head domain associated with the plasma membrane and its rod domain
making numerous cytoskeletal contacts (108).
The

talin-1

head

domain

is

a

member

of

the

FERM

(4.1/Ezrin/Radixin/Moeisin) domain family (109, 110). Canonical FERM
domains, such as that of radixin, consist of F1, F2, and F3 subdomains
adopting ubiquitin, acyl-CoA-binding protein, and PTB/PH domain folds,
respectively, and are assembled into a trefoil arrangement (Figure 3.1 A
and B). The talin-1 FERM domain contains a fourth subdomain, F0,
preceding F1 that also adopts a ubiquitin-like fold (111). The four talin-1
subdomains have an extended, nearly linear, configuration (PDB code
3ivf, Figure 3.1C) (104). Whereas radixin binds its targets, such as the
CD44 CT, in a groove formed by helix α1 and strand β5 of its F3
subdomain in an anti-parallel β-β fashion (Figure 3.1A), the talin-β integrin
CT complex contains a second interface with the N-terminal helical portion
of the CT (Figure 3.1D) (61, 112). This positions talin to modulate
interaction between membrane-proximal cytosolic and transmembrane
segments of integrin α and β subunits (1, 61, 112).
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Figure 3.1 Comparison of the Talin-1 and Radixin FERM domains.
(A) The radixin FERM domain is composed of three subdomains: F1 (left,
orange), F2 (center, yellow), and F3 (right, green). The CD44 cytoplasmic
tail (blue) binds to a cleft in F3 formed by helix α1 and strand β5. (B) The
radixin subdomains adopt a canonical trefoil shape. (C) The talin-1 FERM
domain contains F1 (orange), F2 (yellow), and F3 (green) domains, as
well as an F0 subdomain (red) that precedes F1. Instead of a trefoil, the
talin-1 FERM subdomains are arrayed linearly. (D) Model of talin-1 F3
(green) bound to the integrin β1D CT (black). Two regions of the β1D CT
interact with talin-1 F3: its C-terminal portion adopts an extended
conformation and packs against a ridge formed by the interface of helix α1
and strand β5 in F3, while an N-terminal α-helix and a contiguous portion
of the β1 transmembrane (TM) domain packs against the top of F3.
Radixin structures were generated from PDB 2zpy. Talin-1 structures
were modeled using PDB 3g9w and PDB 3ivf.
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Here,

we

examine

the

thermodynamic

interplay

between

phospholipid bilayers and β CT binding sites in the talin-1 FERM domain.
The impetus for this study arose, in part, from conflicting findings
regarding the ability of the talin-1 FERM domain to interact with the β3 CT.
In solution, the affinity of talin-1 for β integrin CTs is nearly 1000-fold
weaker than the affinity of radixin for CD44 (113) or of talin-1 for the Cterminus of PIP5KI-γ (61). However, talin-1 binds to the β3 CT with high
affinity when the CT is immobilized on a carboxy-methylated dextran
surface (114). This suggests that the interaction of talin-1 with integrins is
optimal when the β subunit CT is presented on a hydrophilic negativelycharged surface such as the inner leaflet of plasma membranes.
To assess the interplay between membrane and β CT binding
interactions, we tested whether the talin-1 FERM subdomains F0F1 and
F2F3 (Figure 3.2B and C), each of which can interact with membranes
(111), bind cooperatively or independently to a variety of negatively
charged lipids and compared their binding to the complete FERM domain
(F0-F3, Figure 3.2A). We then measured the effect of the membrane
environment on the affinity of FERM domain binding to the β3 CT. We
found that although the membrane environment increased the overall
affinity of the FERM domain for β3, the interactions between the FERM
domain, the β3 CT, and lipid bilayers were not optimized for a high-affinity
synergistic interaction, even at the membrane surface. Instead, the
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interactions appeared to be tuned in such a way that the equilibrium
between inactive and active integrin conformations can be readily
regulated.
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Figure 3.2 Talin-1 and αIIbβ
β3 constructs used.
Talin-1 constructs encompassing the (A) F0, F1, F2, and F3 subdomains,
(B) the F0 and F1 subdomains, and (C) the F2 and F3 subdomains. Each
construct contains an N-terminal Gly-Ser-His-Met (GSHM) motif enabling
cleavage by thrombin. (D) β3 CT constructs include the entire CT
including the talin-1 recognition motif (bold) and preceded by a Cys
residue at position 719 as well as an N-terminal GSHMG sequence for
cleavage by thrombin (top); a fluorescent β3 CT construct in which a
maleimide-BODIPY-TMR moiety is appended to C719 (middle); and a β3
CT construct in Cys719 was covalently modified with maleimidefunctionalized phosphatidylethanolamine (bottom).
(E) FITC-labeled
peptide derived from PIP5KIγ. {All talin and integrin constructs cloned,
expressed, and purified by DTM. PIP5K1γ was synthesized by HJ.}

II. Results
The talin-1 FERM domain contains an extended positivelycharged surface.
Projection of an electrostatic surface on the talin-1 FERM domain
revealed that it contains an extended positively-charged surface (Figure
3.3) (104). This is especially pronounced for the F2 and F3 subdomains.
The F0 and F1 subdomains also contain positively charged surfaces and
F1 contains a flexible loop that readily binds to membranes but was
removed for crystallization (107). The positively-charged surfaces on F0F1
are not completely aligned with those on F2F3. Although this could reflect
a strong bias for maintaining the surfaces in an unaligned state in solution
or the selection of a single conformation from a flexible ensemble due to
crystal packing, X-ray scattering studies argue against a flexible ensemble
of structures (104). Thus, if the solution conformation is maintained, F0F1
should make only modest contributions toward the affinity of the overall
complex over that of the F2F3 alone. Alternatively, if F0F1 and F2F3
change their mutual orientation away from the minimum energy solution
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conformation, this would attenuate the affinity relative to the value
expected if they were pre-organized to interact favorably with the surface.

Figure 3.3 Orientation of the talin-1 FERM domain with respect to the
inner leaflet of the plasma membrane.
As in Figure 3.1, the talin-1 F0-F3 subunit bound to a β-integrin was
modeled using the crystal structure of the talin-1 FERM domain (pdb code
3ivf). (A) The interaction of talin-1 with the β integrin CT (black) places its
FERM domain in proximity to the inner plasma membrane leaflet. (B)
59

Projection of an electrostatic surface onto the talin-1 FERM domain. Red
denotes negative and blue denotes positive-charge density. (C) Talin-1
FERM domain rotated 90° showing the electrostatic surface as viewed
from the membrane (left) and cytosol (right). {Models were generated by
DTM using PyMOL}

Binding of the talin-1 FERM domain fragment F2F3 to
negatively-charged phospholipids.
Before studying the interaction of the talin-1 FERM domain with the
β3 CT tethered to membrane, we investigated whether the F2F3
subdomain, which makes the most direct contact with the β3 CT,
differentially recognizes negatively-charged phospholipids.

We used

surface plasmon resonance (SPR) to measure the interaction of F2F3 with
phospholipid bilayers immobilized on a hydrophobically-modified Biacore
L1 SPR chip (115). All measurements were made relative to a surface
containing 100% phosphatidylcholine (PC). F2F3 binding to 20% POPS
and 80% POPC was measured at steady state (Figure 3.4A) and
conformed to a single-site binding model as a function of F2F3
concentration. The dissociation constant (Kd) for F2F3 binding to 20%
phosphatidylserine (PS)-containing bilayers was 0.92 µM (Table 3.1). In
comparison, the Kd for bilayers containing 10% PtdIns(4,5)P2 was 0.67
µM, suggesting that the F2F3 may have a slight preference for
PtdIns(4,5)P2 over PS. Nonetheless, F2F3 bound to bilayers containing
the

diphosphoinositides

PtdIns(3,5)P2

and

PtdIns(3,4)P2

and

the

monophosphoinositide PtdIns(5)P with affinities similar to PtdIns(4,5)P2
and largely within the error of measurements (Figure 3.4B, Table 3.1),
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indicating that it does not strongly differentiate between the negatively
charged head groups.
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Figure 3.4 Steady state binding of the talin-1 FERM domain and its
subdomains to phospholipid bilayers.
(A) SPR sensorgrams of F2F3 binding to a bilayer composed of 20%
POPS and 80% POPC immobilized on a Biacore L1 SPR chip. F2F3 was
injected in 2-fold increments up to a concentration of 10 µM. (B) Steadystate isotherms for F2F3 binding to negatively-charged phospholipids.
Diamonds, 10% PtdIns(4,5)P2; squares, 10% PtdIns(3,5)P2; triangles,
10% PtdIns(3,4)P2, Xs, PtdIns(5)P, circles, 20% phosphatidylserine. (C)
Steady-state isotherms for F0-F3 (squares), F2F3 (triangles), and F0F1
(diamonds) binding to bilayers containing 10% PtdIns(4,5)P2. Data from
(B) and (C) were fit to a one-site binding model using BIAevaluation
software. {Three independent experiments were performed. Protein was
purified by DTM. SPR was performed by PN. Data analysis was
performed by DTM and PN.}
Table 3.1 Steady-state SPR measurements of talin-1 F2F3 subdomain
binding to phospholipids.
Binding to the indicated phospholipids (Figure 3.4B) was fit to a one-site
binding model using BIAevaluation. The data represent the mean and
standard deviations of three independent experiments.
Lipid (%)

Kd (µM)

Maximum
(RU)

PS (20%)

0.92 ± 0.260

1210 ± 66

PtdIns(4,5)P2 (10%)

0.67 ± 0.07

2490 ± 225

PtdIns(3,4)P2 (10%)

0.42 ± 0.09

2170 ± 146

PtdIns(3,5)P2 (10%)

0.50 ± 0.053

2330 ± 193

PtdIns(5)P (10%)

0.37 ± 0.029

1770 ± 146

Binding

The total amount of F2F3 bound to bilayers depended on the net
negative charge of the membrane, suggesting that electrostatics play a
substantial role in the interaction. PtdIns(4,5)P2, PtdIns(3,5)P2, and
PtdIns(3,4)P2 each have a charge of (-4) per head group, while PtdIns(5)P
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has a charge of (-3), and PS has a charge of (-1). If the interaction were
dependent of charge, the amount of protein bound to 10% PtdIns(5)P,
would be expected to be roughly ¾ the amount bound to 10%
diphosphoinositides. Similarly, ½ as much talin-1 would be expected to
bind to 20% PS as to 10% diphosphoinositides. The maximum resonance
units (RU) of F2F3 bound to 10% PtdIns(4,5)P2, 10% PtdIns(3,5)P2, and
10% PtdIns(3,4)P2 were similar at 2490, 2330, and 2170 RU, respectively.
We found that approximately ¾ the amount of F2F3 bound to 10%
PtdIns(5)P (1770 RU) and ½ the amount bound to 20% PS (1200 RU),
confirming that total protein bound depends on the charge of the
membrane.

Binding of talin-1 FERM domain and its subdomains to
PtdIns(4,5)P2.
Next, we compared the affinity of the complete talin-1 FERM
domain (F0-F3) for PtdIns(4,5)P2 with that of F0F1 and F2F3.
PtdIns(4,5)P2 was chosen as the lipid substrate for these measurements
because F2F3 did not differentiate between various phosphoinositides.
Phospholipid bilayers containing 10% PtdIns(4,5)P2 were immobilized on a
Biacore L1 chip and all measurements were made relative to a surface
containing 100% PC. We found that F0-F3 bound to 10% PtdIns(4,5)P2
with a Kd of 980 nM, comparable to the Kd for F2F3 of 670 nM, whereas
the Kd for F0F1 was 2.6 µM (Table 3.2). Thus, both F0F1 and F2F3
readily interact with PtdIns(4,5)P2, but when combined, the affinity for
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bilayers was not enhanced. The relative stoichiometries of F0F1, F2F3,
and F0-F3 also suggest that the subdomains do not form a cooperative
membrane binding surface. The mass ratios for F0-F3, F2F3, and F0F1
are 2:1.1:1.0. F0-F3 has twice the mass of F2F3 and nearly twice the
resonance units of F0-F3 (3960 RU) bound to the sensor chip as F2F3
(2490 RU) (Figure 3.4C, Table 3.2). Thus, F0-F3 and F2F3 have similar
stoichiometries for the phospholipid surface. A similar amount of F0F1
bound to the sensor chip (2290 RU) as F2F3, but with lower affinity. Thus,
although F0F1 can

interact

with PtdIns(4,5)P2, the

affinity and

stoichiometry of the full FERM domain for PtdIns(4,5)P2 is similar to that of
F2F3, indicating that F0F1 does not substantially cooperate with F2F3 in
FERM domain binding to membranes.

Table 3.2 Steady-state SPR measurements of talin FERM domain
binding to phospholipid bilayers containing 10% PtdIns(4,5)P2.
Binding results were fit to a one-site binding model using BIAevaluation.
The data shown represent the mean and standard deviation of three
independent experiments.

FERM
construct

domain Kd (µM)

Maximum
(RU)

F0-F3

0.98 ± 0.10

3960 ± 258

F2F3

0.67 ± 0.07

2490 ± 220

F0F1

2.63 ± 0.84

2290 ± 258
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Binding

Enthalpy of talin-1 FERM domain binding to PtdIns(4,5)2.
It has been reported that the talin-1 FERM domain bind to
negatively-charged vesicles in solution (104, 105, 111, 116, 117). To
confirm these observations, we used isothermal titration calorimetry (ITC)
to measure the enthalpy of F0-F3 binding to large unilamellar vesicles
(LUVs) composed of 90% POPC and 10% PtdIns(4,5)P2. As a positive
control, we measured binding of the pleckstrin homology (PH) domain of
PLC-δ1 to PtdIns(4,5)P2 (30).
Titration of 100 µM PLC-δ1 PH domain into a LUV suspension
containing 1%, 3%, and 10% PtdIns(4,5)P2 generated binding isotherms
with molar enthalpies of -11.7 kcal/mol, -10.2 kcal/mol, and -12.8 kcal/mol
and dissociation constants of 2.8 µM, 2.1 µM, and 4.2 µM, respectively
(Figure 3.5A, Table 3.3). These results are comparable to a previously
published binding enthalpy of -11.9 kcal/mol and Kd of 1.1 µM for PLC-δ1
PH domain binding to 1% PtdIns(4,5)P2 bilayers (30).
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Figure 3.5 Comparison of PLC-δ
δ1 PH domain and talin-1 FERM
domain binding to PtdIns(4,5)P2 and Ins(1,4,5)P2.
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(A) ITC titration of 100 µM PLC-δ1 PH domain into LUVs containing 1%
(X), 3% (open squares), and 10% (closed squares) PtdIns(4,5)P2. The
titrations were globally fit to a OneSite binding model using
MicroCal/Origin. (B) ITC titration of 190 µM talin-1 FERM domain (F0-F3)
into LUVs containing 1% (X), 3% (open squares), and 10% (closed
squares) PtdIns(4,5)P2 No enthalpy was generated for 1% or 3% LUVs.
Titration into 10% PtdIns(4,5)P2 was globally fit to a OneSite binding
model using MicroCal/Origin. (C) Steady-state binding isotherms for F0-F3
binding to 1% (triangles), 3% (squares) and 10% (diamonds) PtdIns(4,5)P2
immobilized on a Biacore L1 SPR chip. {PLC-δ1 ITC titrations were
performed once to demonstrate accessibility of the PtdIns(4,5)P2
headgroup. Talin-1 titration into 1% and 3% PtdIns(4,5)P2 were performed
in triplicate independent experiments. Talin-1 titration into 10%
PtdIns(4,5)P2 was performed in triplicate with the same protein sample.
SPR data are representative of three independent experiments. ITC
experiments were performed by DTM. DTM prepared protein samples for
SPR experiments. PN performed SPR experiments. DTM and PN
analyzed SPR data.}

Table 3.3 ITC measurements of talin-1 FERM domain and PLC-δ
δ1
binding to PtdIns(4,5)P2 and Ins(1,4,5)P3.
Measurements were performed at 20ºC in 25 mM MOPS pH 6.8 with 100
mM NaCl. Background heats of dilution were subtracted. Titrations were
fit to OneSite binding isotherms using MicroCal/Origin and errors are
reported as fitting errors. There was no net enthalpy for titration of F0-F3
into 1% and 3% PtdIns(4,5)P2 and 2 mM Ins(1,4,5)P3. {PLC-δ1 ITC
experiments were performed once to demonstrate accessibility of
PtdIns(4,5)P2 on the bilayer surface – errors represent fitting errors. Talin1 titration into 1% and 3% PtdIns(4,5)P2 were performed in triplicate
independent experiments. Talin-1 titration into 10% PtdIns(4,5)P2 was
performed in triplicate with the same protein sample. Talin-1 errors are
standard deviations. }

Kd (µµM)

∆H (kcal/mol)

∆S (cal/mol/K)

n

F0-F3 + 1% -------PtdIns(4,5)P2

--------

--------

--------

--------

F0-F3 + 3% -------PtdIns(4,5)P2

--------

--------

--------

--------

Ka (x106 M-1)
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F0-F3 + 10% 1.3 ± 0.6
PtdIns(4,5)P2

0.781

-3.3 ± 0.4

-17.0

0.33 ± 0.03

F0-F3 + 2 -------mM
Ins(1,4,5)P3

--------

--------

--------

--------

PLC-δ1 + 1% 0.36 ± 0.08
PtdIns(4,5)P2

2.82

-11.7 ± 1.0

-14.0

1.13 ± 0.07

PLC-δ1 + 3% 0.47 ± 0.03
PtdIns(4,5)P2

2.11

-10.2 ± 0.2

-8.37

0.97 ± 0.01

PLC-δ1 +10% 0.24 ± .02
PtdIns(4,5)P2

4.20

-12.8 ± 0.7

-18.3

0.75 ± 0.03

PLC-δ1 + 2 1.4 ± 0.2
mM
Ins(1,4,5)P3

0.72

-17.5 ± 0.7

-30.5

0.80 ± 0.02

Next we titrated 190 µM F0-F3 into a suspension of LUVs
composed of 90% POPC and 10% PtdIns(4,5)P2. After subtracting the
heat of dilution, F0-F3 binding was slightly exothermic (≈ -3 kcal/mol) with
a stoichiometry of ≈ 1 F0-F3 to 3 PtdIns(4,5)P2 phospholipids (Figure
3.5B). Titration of higher F0-F3 concentrations resulted in precipitation of
the mixture in the calorimetry cell – confirming the interaction of F0-F3
with membranes, but precluding thermodynamic analysis. Surprisingly,
similar experiments using LUVs containing 1% and 3% PtdIns(4,5)P2 did
not generate measurable enthalpy (Figure 3.5B). Therefore, to confirm
that F0-F3 actually binds to bilayers containing 1% and 3% PtdIns(4,5)P2,
we measured the interaction by SPR and found that it bound with high
affinity (Figure 3.5C, Table 3.4). Furthermore, the amount of F0-F3 bound
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to the chip scaled with the amount of PtdIns(4,5)P2 on the surface. The
Rmax for 10% PtdIns(4,5)P2

was approximately 10 fold that for 1%

PtdIns(4,5)P2. The Rmax ratio of 10% to 3% PtdIns(4,5)P2 was 4.4, which
was greater than the expected 3.3. All other SPR measurements with
F0F1, F2F3, and F0-F3 have Rmax values that scale appropriately with
phospholipid charge and protein mass (Tables 3.1 and 3.2), therefore it is
unclear why the 3% PtdIns(4,5)P2 surface would deviate. The experiment
was repeated several times with different protein preparations and lipid
stocks.

Table 3.4 Steady-state SPR measurements of talin F0-F3 domain
binding to phospholipid bilayers containing 10%, 3%, and 1%
PtdIns(4,5)P2.
Binding results were fit to a one-site binding model using BIAevaluation.
The data shown represent the mean and standard deviation of three
independent experiments.

Negatively
Charged Kd (µM)
Phospholipid

Maximum
(RU)

10% PtdIns(4,5)P2

0.98 ± 0.10

3960 ± 258

3% PtdIns(4,5)P2

0.70 ± 0.21

901 ± 57

1% PtdIns(4,5)P2

0.65 ± 0.28

427 ± 24

Binding

Lastly, we attempted to measure the interaction of F0-F3 with the
inositol headgroup of PtdIns(4,5)P2, Ins(1,4,5)P3, free in solution (Figure
3.6). Two mM Ins(1,4,5)P3 was titrated into a 150 µM F0-F3 solution, but
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no binding enthalpy was generated. By contrast, titration of 120 µM
Ins(1,4,5)P3 into a 6 µM solution of the PLC-δ1 PH domain generated an
exothermic binding curve with thermodynamic parameters comparable to
previously published results (Table 3.3) (30).

Figure 3.6 Titration of Ins(1,4,5)P3 into talin-1 F0-F3 does not
generate significant enthalpy.
ITC titrations of 2 mM Ins(1,4,5)P3 into 150 µM F0-F3 (filled squares) and
120 mM Ins(1,4,5)P3 into 6.0 mM PLC-δ1 (open squares). The titration
into PLC-δ1 could be fit to a OneSite model (MicroCal/Origin). All samples
were prepared in buffer matched 25 mM MOPS 100 mM NaCl, pH 6.8.
Background heats of dilution were subtracted. {Titration of Ins(1,4,5)P3
into F0-F3 is representative of two independent experiments. Titration of
Ins(1,4,5)P3 into PLC-δ1 was performed once to demonstrate activity of
Ins(1,4,5)P3. Experiments performed by DTM.}
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Talin-1 FERM domain binding to the β3 CT immobilized on
negatively charged carboxymethylated dextran.
Previous measurements of talin-1 FERM domain binding to the β3
CT used a β3 construct beginning at Lys716 and included a linker for
attaching the construct to an SPR chip (114). Our β3 CT construct,
designed to mimic the β3 CT as it exits the membrane, was attached via
Cys719 to a CM-5 SPR sensor chip functionalized with N-[εmaleimidocaproic acid]-hydrazide to generate thiol-reactive groups (Figure
3.2). F0-F3 was then flowed over the chip at concentrations up to 1.0 µM.
The resulting sensorgrams (Figure 3.7A) could be fit to two binding events
with dissociation constants of 155 nM and 3.5 µM. The biphasic behavior
could have resulted from heterogeneity of β3 on the chip surface or
heterogeneity

of

the

interaction

between

F0-F3

and

the

carboxymethylated dextran (118). Regardless, the interaction between the
talin-1 FERM domain and the β3 CT may be sensitive to such
heterogeneity since we hypothesize that the FERM domain binds to the β3
CT and the inner membrane surface simultaneously. We chose not to
pursue experiments with carboxy-dextran-immobilized integrin further, as
membrane immobilized β3 is more biologically relevant and immobilization
of small peptides on dextran matrices can result in heterogenous
interaction surfaces.
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Figure 3.7. Talin-1 FERM domain binding to the β3 CT immobilized on
negatively-charged surfaces or free in solution.
(A) The β3 CT (600 RU) was immobilized on a carboxy-methylated
dextran SPR chip and F0-F3 to maximum concentration of 1 µM was
flowed over the chip. (B) FP of F0-F3 titrated into 20 nM BODIPY-TMR
β3. FP was measured at 575 nm after excitation at 530 nm (squares). F073

F3 was also titrated into a 20 nM FITC-labeled PIP5KI-γ (black circles). FP
was measured at 528 nm after excitation at 485 nm. (C) ITC of 140 µM β3
CT titrated into buffer-matched 10.5 µM F0-F3 revealed no significant
enthalpy above the heat of dilution. ITC samples were in 25 mM MOPS
100 mM NaCl, pH 6.8. {SPR data are representative of two independent
experiments. Fluorescence polarization experiments were performed in
triplicate using the same protein sample. ITC data are representative of
three independent experiments – no binding enthalpy was generated in all
three experiments. SPR was performed and analyzed by PN using
protein prepared by DTM. FP performed by DTM. PIP5K1γ peptide was
prepared by HJ. Integrin peptide was prepared by DTM. ITC performed
by DTM.}

Binding of the talin-1 FERM domain to the β3 CT domain
tethered to negatively-charged bilayer.
To address whether the talin-1 FERM domain binds the β3 CT and
a negatively-charged surface in a concerted fashion, we first used
fluorescence polarization (FP) and ITC to measure the affinity of talin-1
FERM domain for the β3 CT when both are free in solution.
For FP, the β3 CT was labeled with maleimide-functionalized
BODIPY-TMR at Cys719. When F0-F3, at concentrations up to 100 µM,
was titrated into a 20 nM solution of labeled β3 CT, the FP increased from
0.1 to 0.16. (Figure 3.7B). These results were fit to a binding isotherm
with a Kd of approximately 600 µM. Since the interaction between talin-1
and β3 CT was not saturated at the concentrations used, the exact
dissociation constant could not be calculated, however other laboratories
have reported values on the order of several hundred micromolar (62,
112), which is in line with our results. As a positive control for talin-1
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activity, we titrated F0-F3 into a 20 nM solution of a fluorescein
isothiocyanate (FITC)-labeled peptide corresponding to the C-terminus of
PIP5KIγ (Figure 3.7B). The resulting change in FP was fit to an isotherm
with a Kd of 160 nM ± 50 nM, consistent with reported affinities of 170 nM
to 1.4 µM for other PIP5KIγ constructs with slightly different sequences
(119, 120).
We also used ITC to confirm that the β3 CT and F0-F3 does not
interact strongly in solution. There was no significant enthalpy above
background heats of dilution when F0-F3, up to a final concentration of ≈
30 µM protein, was titrated into 10 µM peptide (Figure 3.7C). This
contrasts with a recent report in which talin-2 and the β1D cytoplasmic
domain interacted with a Kd of ≈ 20 µM and a molar enthalpy of ≈ -17
kcal/mol (112).

This difference is associated with several subtle but

significant differences between the β1D CT and β3 CT sequences. Our
result can be interpreted either as a lack of interaction between talin-1 and
the β3 CT at the concentrations used or a lack of significant enthalpy at
the concentrations used. Given that the structural similarity of the talin-2 /
β1D interaction (∆H ≈ -17 kcal/mol), we would expect the β3 interaction to
have measurable enthalpy at the concentrations used in this experiment.
Furthermore, the lack of observed enthalpy corroborates our FP data and
previously published NMR experiments (62, 112).
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Figure 3.8. Talin-1 FERM domain binding to the β 3 CT conjugated to
phospholipid bilayers containing 1% PtdIns(4,5)P2.
The β3 CT at a final concentration of 5 µM was immobilized onto the
surface of LUVs containing 1% PtdIns(4,5)P2 (20 µM)/ 2% maleimide-PE
(40 µM) / 97% POPC (2 mM total lipid). Buffer matched talin-1 FERM
domain (F0-F3, 150 µM) was titrated at 20°C into the suspension of
immobilized β3. Background heats of dilution were subtracted. The
titration was globally fit to a OneSite binding model using MicroCal/Origin.
All ITC experiments were performed in 25 mM MOPS buffer 100 mM
NaCl, pH 6.8. Thermodynamic parameters are summarized in Table 3.5.
{Data represent three independent experiments. Experiments performed
by DTM.}

Because the interaction between the talin-1 FERM domain and
PtdIns(4,5)P2 occurs with very low enthalpy, we were able to use ITC to
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measure talin-1 FERM domain binding to the β3 CT in the presence of
PtdIns(4,5)P2. Accordingly, we immobilized the β3 CT on phospholipid
bilayers by reacting a β3 CT construct containing Cys at residue 719 with
maleimide-functionalized phosphatidylethanolamine on the surface of
LUVs composed of POPC and 1% PtdIns(4,5)P2, 20% PS, or 20% PS +
1% PtdIns(4,5)P2 (1). Titration of F0-F3 into a suspension of LUVs
containing 1% PtdIns(4,5)P2 in the absence of immobilized β3 CT (Figure
3.5B) or into buffer containing the free β3 CT (Figure 3.4C) generated little
or no enthalpy.

By contrast, titration of 150 µM F0-F3 into a LUV

suspension containing 5 µM β3 CT immobilized on 1% PtdIns(4,5)P2 was
exothermic (Figure 3.8). The titration was globally fit to a one-site binding
isotherm, revealing a Kd of 860 nM and a molar enthalpy of -25.0 kcal/mol
(Table 3.5).

When the experiments were repeated with the β3 CT

immobilized on bilayers containing 20% PS or 20% PS with 1%
PtdIns(4,5)P2 similar results were obtained (Figure 3.9A/B; Table 3.5).
Thus, these experiments demonstrate that immobilizing the β3 CT on
phospholipid bilayers increases its affinity for the talin-1 FERM domain by
at least three orders of magnitude compared to the β3 CT free in solution,
increasing its affinity from that of a very weak to a high-affinity interaction.
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Figure 3.9 FERM domain binding to the β 3 CT conjugated to
negatively-charged phospholipid bilayers.
As in Figure 3.5k, the talin-1 FERM domain (F0-F3, 150 µM) was titrated
at 20°C into a buffer-matched suspension of LUVs composed of (A) 20%
PS or (B) 20% PS + 1% PtdIns(4,5)P2 to which 5 µM β3 CT had been
conjugated via a maleimide-functionalized lipid head group (Methods).
The titrations were globally fit to a OneSite binding model using
MicroCal/Origin. Thermodynamic parameters are summarized in Table
3.5. {Data are representative of triplicate experiments performed with the
same protein sample. Experiments were performed by DTM.}

Table 3.5 ITC measurements of talin-1 FERM domain binding to the
β3 CT attached to large unilamellar phospholipid vesicles (LUVs).
The talin-1 FERM domain was titrated into LUV suspensions containing 5
µM immobilized β3 CT (Figures 3.8 and 3.9). All experiments were
performed at 20ºC in 25 mM MOPS pH 6.8 with 100 mM NaCl and
background heats of dilution were subtracted. Titrations were fit to onesite binding isotherms. {Titration into β3 on 1% PtdIns(4,5)P2 was
performed as three independent experiments and errors are reported as
standard deviations. Titration into β3 on 20% PS and 20% PS with 1%
PtdIns(4,5)P2 was performed once with each sample and the error is
reported as the fitting error. All experiments were performed by DTM.}
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Ka (x106 Kd
-1
M )
(µ
µM)

∆H(kcal/mol)

∆S(cal/mol/K) n

1.19
β31%PtdIns(4,5)P2 0.21

± 0.86

-25.0 ± 1.5

-55.8

0.80
0.04

β3-20% PS

0.29
0.02

± 3.4

-32.3 ± 0.9

-83.3

0.8
(held)

β3-20%PS
+ 0.61
1%PtdIns(4,5)P2 0.11

± 1.6

-34.0 ± 2.8

-87.5

0.95
.06

±

±

III. Discussion
Here we found that presentation of the β3 CT in the context of an
acidic bilayer enhances its affinity for the talin-1 FERM domain up to three
orders of magnitude, depending on the phospholipid composition of the
bilayer. However, FERM domain binding to the β3 CT contrasts with the
stronger interaction of the FERM domain with PIP5K1γ and with the
interaction of the talin-2 FERM domain and the β1D CT. Small changes in
integrin β CT sequences have been shown to significantly increase their
affinities for talin family FERM domains (112). This suggests that the
interaction between the talin-1 FERM domain and the β3 CT has been
evolutionarily tuned to be intrinsically weak, allowing it to be modulated by
changes in phospholipid composition, post-translational modifications, and
additional protein-protein interactions.
To

understand

how

these

protein-protein

and

lipid-protein

interactions modulate affinity, it is important to consider the various
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energetic components associated with the interaction of the talin-1 FERM
domain and the β3 CT with lipids, as well as their interaction with each
other. Previous studies reported the interaction of the talin-1 FERM
domain and the β3 CT with micelles and phospholipid vesicles (1, 16, 38,
54, 106). Here, we studied this interaction using the β3 CT tethered to
phospholipid bilayers to understand the energetics of the overall process.
Previously, we used this construct to study the dynamics of the β3 CT in
the presence of bilayers by hydrogen-deuterium exchange (HDX).
Although the construct lacks a transmembrane domain, it was designed
computationally to attach via a residue predicted to be at the membrane
interface and it contains all of the β3 residues necessary for interaction
with talin-1.

While it is possible that the TM domain could affect this

interaction, our NMR and HDX studies indicate that the TM helix is broken
by a kink as it exits the membrane, implying that the structure of the β3 CT
distal to the helix disruption is unlikely to depend on residues buried within
the membrane. Furthermore, our construct contains all of the β3 residues
necessary for formation of the kink (Figure 2.5).
We can consider the overall free energy for the interactions of the
bilayer-tethered β3 CT (RTln(Kobs) = ∆Goverall) in terms of several
components according to Eq. 1 below. It should be noted that this
thermodynamic decomposition is path-independent and does not require
kinetic ordering; nevertheless, all interactions here were rapid, on the
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second to msec time scale, indicating that they might rapidly interconvert
on a physiologically relevant time scale.
Eq. 1: ∆Goverall = ∆Gtalin-bilayer + ∆Gtalin-peptide + ∆Greorganization
where:
∆Gtalin-bilayer is the energy associated with talin-1 head interaction with lipid,
as determined directly from the titration of the FERM domains into lipid
bilayers;
∆Gtalin-peptide is the energy associated with talin-1 head interaction with the
β3 CT, as determined directly from the NMR or the fluorescent titrations
reported above and which is sequence-specific (112) but only weakly
favorable (Kdiss on the order of 0.2 to 0.6 mM).
∆Greorganization is the free energy required to rearrange the conformations of
isolated individual components and binary complexes to allow formation of
a ternary complex.
The electrostatic surfaces of F3, F2F3, and the full FERM domain
(44, 104) suggest that F2F3 binds negatively-charged bilayers in a
manner highly conducive to forming a simultaneous interaction with the β3
CT; this finding has been supported by detailed coarse-grained molecular
dynamics calculations (106). Thus, there is likely little reorganization
energy associated with the interaction of these subdomains with bilayers.
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By contrast, the β3 CT, tethered to a bilayer, is in a rapid equilibrium that
favors a conformation in which the peptide interacts with the membrane in
a way that masks residues important for talin-1 binding and that would
otherwise be located 10 – 30 Å into the cytoplasm (1).

A second

minor conformation is more exposed to the aqueous surroundings,
presumably allowing rapid kinetic access to the FERM domain.
Hydrogen-deuterium exchange showed that the equilibrium favors the
membrane-associated state by 100 to 1000-fold relative to the exposed
state (Chapter 2), decreasing the overall affinity for binding cytosolic
proteins by an equivalent amount. Thus, we expect that ∆Grearrange would
be dominated by the rearrangement of the β3 CT within the bilayer.
Consideration of Eq. 1 shows that cytosolic protein binding to the
β3 CT in a proper context depends on an energetic balance, which, in this
case, includes a highly favorable interaction between talin-1 and the
membrane. A modestly favorable free energy of interaction of the β3 CT
with the talin-1 head is balanced by a modestly unfavorable free energy of
rearrangement of the β3 CT within the bilayer. In net, the observed affinity
for formation of the ternary complex remains similar to that for the binary
interaction of the talin-1 head with acidic bilayers. Likewise, in the absence
of integrin, the binary complex between the FERM domain and the
membrane appears to energetically favor the F2F3 subunit, as F0F1 does
not affect the overall affinity or stoichiometry of the interaction. This
suggests that F0F1 might not interact favorably with the bilayer once it is
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tethered in place by the more stable F2F3 interaction. Alternatively, F0F1
might interact extensively when the FERM domain binds, but only after an
energetically uphill conformational change that attenuates the overall
affinity gain associated with F0F1-bilayer interaction.

It is likely not

accidental that the binary and ternary complexes are not optimized for
cooperativity. Rather they appear to be tuned to be readily regulated by
changes in the lipid environment and by post-translational modifications.
In summary, our studies reveal the rich interplay between structure,
dynamics, kinetics, and thermodynamics that govern formation of the
ternary complex between the β3 CT, phospholipid bilayers, and talin-1
FERM domain. This energetic dissection provides the basis for
understanding how posttranslational modifications and changes in lipid
composition might affect such processes. The situation becomes more
complex as interactions with additional domains in integrin and talin, as
well as other antagonistic or synergistic cytoplasmic proteins, are
considered. Nevertheless, the present study illustrates the importance of
considering

the

role

of

conformational

changes,

structural

rearrangements, and conformational entropy in these processes, and
provides a general approach to energetic decomposition that can form the
basis for understanding regulation of even more complex systems.
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IV. Methods
Design of recombinant talin-1, β3 CT and PIP5K1γ constructs. Talin-1,
β3 CT, and PIP5K1γ constructs were cloned between the NdeI and XhoI
restriction sites of the vector pet28a and contained an N-terminal 6xHis
tag for purification, followed by a thrombin cleavage site for affinity tag
removal. The talin-1 constructs (Figure 3.2, A-C) consisted of the entire
talin-1 FERM domain (F0-F3), extending from its N-terminus through
residue Ser425, the F0F1 subdomains extending from the N-terminus
through residue Asp201, and the F2F3 subdomains spanning residues
Ser206 through Ser425.
The β3 CT construct (Figure 3.2D), encompassing residues Thr720
through the C-terminus at Thr762, was previously described (1). For the
current experiments, residue Ile719 was replaced with Cys to enable the
construct to be immobilized on the surface of bilayers or to be labeled via
maleimide chemistry. A peptide corresponding to residues 646-654 of
PIP5K1γ was also labeled with fluorescein isothiocyanate (FITC) (Figure
3.2E).
Talin-1 and PIP5K1γ were introduced into BL21-DE3 cells
(Novagen) and expressed for 20 h at 20°C in the presence of 0.5 mM
IPTG. Cells were then lysed by sonication on ice in 20 mM imidazole
buffer, pH 7.0, containing 500 mM NaCl, 1 mM EDTA, and a protease
inhibitor cocktail (Sigma-Aldrich).

After the lysates were cleared by
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centrifugation, the supernatants were loaded onto HiTrap Ni-NTA columns
(GE Healthcare) and peptides were eluted using an imidazole gradient.
Imidazole was dialyzed away overnight into 50 mM Tris buffer, pH 7.5
containing 100 mM NaCl and the 6xHis tag was removed using thrombin.
The constructs were then purified by SP ion exchange chromatography
(GE Healthcare) and finally size exclusion chromatography with a
Superdex 75 preparative column (GE Healthcare).
Preparation of large unilamellar vesicles (LUVs).

LUVs were

generated by evaporating a mixture of 1-palmitoyl-2-oleoyl-sn-glycero-3phosphocholine (POPC, Avanti Polar Lipids) and 1-palmitoyl-2-oleoyl-snglycero-3-phospho-L serine (POPS, Avanti Polar Lipids) dissolved were
dissolved in chloroform under nitrogen; excess chloroform was removed
under high vacuum overnight. Phosphoinositides (Cell Signaling) were
dissolved in CHCl3/MeOH/0.1% HCl, mixed with POPC, and dried under
nitrogen. Evaporated lipids were then re-suspended in buffer, vortexed
vigorously for 5 minutes, subjected to 3 x freeze- thaw cycles, and
extruded 20 to 30 times using 100 nm diameter filters (Avanti Polar
Lipids).
Preparation of membrane tethered β3. Lyophilized β3 CT was redissolved in bilayer conjugation buffer (25mM sodium phosphate or
MOPS, 100 mM NaCl, pH 6.8) at a concentration of 50 µM.

Large

unilamelar vesicles (LUVs) were generated by evaporating a mixture of
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1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[4-(pmaleimidomethyl)cyclohexane-carboxamide] (16:0 PE MCC, Avanti Polar
Lipids), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC, Avanti
Polar Lipids), and the appropriate negatively charged lipid under nitrogen.
The lipids re-suspended in the bilayer conjugation buffer.

LUVs were

prepared by extruding 20 times through a 0.1 µm filter (Avanti Polar
Lipids). β3 CT was reacted with 4 fold molar excess 16:0 10 PE MCC.
The conjugation reaction was performed at pH 6.8 to minimize lysine
amine-maleimide side reactions which are strongly disfavored at below pH
7. After reacting the β3 CT with the surface of the membrane for three
hours, the bilayers were quenched with excess β-mercaptoethanol and
dialyzed overnight. The final lipid concentration was calibrated using a
POPC standard to calculate the amount of POPC in the β3-conjugated
bilayer.
Isothermal titration calorimetry (ITC). ITC experiments were performed
on a

MicroCa ITC200 (MicroCal/GE). Samples were prepared in

degassed 25 mM 3-(N-morpholino)propanesulfonic acid (MOPS) buffer,
pH 6.8, containing 100 mM NaCl. Samples were loaded into cells after
vigorous washing with buffer and syringes were loaded with 50 µL of
titrant. Each experiment consisted of 20 x 2.0 µL injections spaced at
intervals of 2-5 minutes. A 0.2 µL injection preceded all experiments and
was not included in fitting. Fitting was performed using the Origin software
suite (MicroCal/Origin Systems) as single binding events. Heats of dilution
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were calculated by titration into the prepared diazylate and subtracted
prior to fitting.
Surface plasmon resonance (SPR).

All SPR experiments were

performed on a Biacore 3000 (GE Healthcare). Each injection was done
in triplicate. Kinetic experiments were performed in degassed 10 mM (4(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) buffer, pH 7.2,
containing 100 mM NaCl. The CM5 chip was activated using an amine
coupling kit (GE Healthcare). N-(2-Aminoethyl)maleimide (pH 7.0) was
then injected and non-reacted activated groups were capped with 1 M
ethanolamine (pH 7.0). The β3 CT was immobilized onto the CM5 chip via
maleimide crosslinking to ≈ 600 RU.

Background maleimide was

quenched with 2-mercaptoethanol. Talin-1 FERM domain constructs
were injected at 50 µL/min with a 2 min injection time and 400 sec
dissociation time. Binding data were fit to a double exponential using the
BIAvaluation software.
For steady-state experiments, 100 nm LUVs were loaded onto an L1 chip.
Talin-1 FERM domain constructs were injected for 10 min with a 120 sec
dissociation time and a 10 µL/min flow rate. Between injections, new lipid
surfaces were generated when full dissociation was not observed. Steady
state construct binding was compared to a reference channel containing
100% POPC. Binding was fit to a single component isotherm equation: Req
= (KA * [analyte]*RUmax)/ (KA *[analyte]*n+1)+background.
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Fluorescence Polarization (FP). FP experiments were performed as
previously described (121). Briefly, FP was conducted in an ATF105
spectrofluorometer (Aviv Instrument, Inc) using a 0.3 cm path length
cuvette. Spectra were measured using 1.0 nm slit widths at 25˚C. The β3
CT was labeled with maleimide-BODIPY-TMR at a cysteine introduced at
residue 719. Talin-1 F0-F3 was titrated into 20 nM β3 BODIPY-TMR and
FP was measured at 575 nm after excitation at 530 nm. When F0-F3 was
titrated into 20 nM FITC-labeled PIP5KI-γ, a dissociation constant and
baseline parameters were derived from the fluorescence anisotropy
signal/concentration isotherm using previously described methods (121).
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Chapter 4 Transmembrane communication: general
principles and lessons integrins and other
receptors.
I. Introduction
In this review we explore how the binding of ligands to proteins
induces

functional

conformational

changes.

Ligand

induced

conformational changes are fundamental to every aspect of protein
function; for example, when an enzyme binds its substrate the act of
binding induces changes in the protein’s structure and dynamics to
improve catalysis (122-124). Thus, it is often difficult to separate binding
from catalysis. Similarly, binding of an allosteric ligand can lead to the
propagation of conformational changes over long distances. We focus
primarily on the generation and transmission of conformational changes in
membrane proteins; we first introduce the types and limits of coupled,
ligand induced conformational changes. Next we examine in quantitative
terms the effects of different coupling mechanisms.
We then explore how ligand-binding affects the structures and
functions of various membrane protein including bacterial histidine kinases
and integrins, exploring the mechanisms by which multiple proteins, small
molecules, metal ions, phospholipids, and post-translational modifications
influence their activation and signaling.

Finally, we demonstrate how

interdomain coupling can generate diverse integrin signals.
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II. Results
The coupling of ligand binding and environmental effects to
conformational changes
Ligand binding generally leads to changes in both structure and
dynamics, with increases and decreases in dynamics often occurring at
different sites of the same protein(125). The effect of ligand binding on
protein activity can be viewed in light of classical thermodynamic concepts
of allostery, induced fit or conformational selection, and cooperativity(122127). For simplicity, we consider a two-state transition between an active
and resting state. The experimentally observed change in activity depends
on several factors including: 1) the free energy difference or “energy gap”
between the active and resting states, which determines the fraction of the
protein in the activated state in the absence of the ligand, 2) the affinity of
the protein for the ligand and their concentrations, and 3) the ability of the
ligand to induce a transition when fully bound. Less than complete
activation occurs, even when the ligand is fully bound, if it binds to both
the activated and the resting conformations; in this case, the extent of
activation relates to the relative affinity of the ligand for the activated
versus resting state. These concepts of coupled equilibria are well studied
and understood. Relating these to such phenomena as partial activation,
potentiation, and synergistic ligands, is a simple matter of algebraic bookkeeping, as shown in later sections.
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In the next section, we explore in more quantitative terms how
these simple binding phenomena lead to a variety of activation curves,
when there are multiple ligands capable of activating the protein of
interest. In this case, distinct ligand-binding sites at different locations can
“couple” to give a variety of outcomes; the binding of one can alter the
affinity of the other for the protein, and they can have additive or nonadditive effects on the degree of maximal activation upon ligand
saturation.
The coupling of binding and functional transitions refers to the
phenomenon by which the binding of a ligand to one site influences the
structure, dynamics, and binding affinity at a second site, which relates to
the protein’s energy gap and the ratio of affinities of the regulatory ligand
for the activated versus the resting states. Given these simple
requirements, it is not surprising that coupling can be achieved in different
ways. One special case is when the binding of a ligand induces a change
in association state. When no change in association is observed, it is often
implicitly assumed that signaling occurs via “hard connections” in which
helices shift, tilt or change register, mechanically driving a conformational
change that propagates across a bilayer. A second model involves
communication between subunits, which can involve large-scale or subtle
changes in interactions between domains or between domains connected
by flexible linkers. These different modes of communication can lead to
different outcomes, when one measures the effects of mutations at
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positions between the binding sites. For example, if a domain shifts as a
rigid body, the search for a “pathway” from one location to the other might
give rise to different results than if the transition of structural and dynamic
information occurs by correlated motions of sidechains that propagate in a
two-state manner between the two sites.
Finally, both the magnitude as well as the sign of the energy gap of
a transmembrane (TM) protein depends on the membrane environment.
Any shift in structure that changes the exposure of specific residues or the
width (cross-sectional surface area) of a protein at a given position in the
membrane will make the energy gap sensitive to the physical properties of
the bilayer. Hence, mechanosensitive channels switch on in response to
changes in bilayer tension(128). Potassium channels respond to the
transmembrane electrical potential, and the location and coupling of
cytoplasmic loops and helices changes in response to the fraction of IP
lipids, sphingomyelin, and cholesterol in the bilayer(129-132). Indeed, the
hydrophobic length of transmembrane helices is reflected in the width of
the bilayers in the organelles to which they localize. Additionally, once
located in a given membrane, there is tight coupling between the lipid
environment and the conformation of the protein, as it, for example,
partitions into cholesterol/sphingomyelin rich phases(133, 134).
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Simple models for energetic coupling
Energy gap It is convenient to think of functional proteins as having at
least two thermodynamic states – a resting state and an active state. The
free-energy gap between these, ∆Ggap = Gactive − Ginactive determines the
equilibrium fraction of active protein as f active =

1
. Since
1 + exp(∆Ggap RT )

[

]

the largest possible fraction of the protein in the active state is 1, this also
determines the maximal attainable degree of activation due to binding of
any ligand or perturbation, via A = 1 + exp(∆Ggap RT ). For example, if ∆Ggap
is 0.41 kcal/mol, then at room temperature the fraction activation is 1 3 .
Therefore, even the best activating agent can only result in a 3-fold
increase in activity. However, if ∆Ggap is 6.82 kcal/mol, the maximal
degree of activation is 105.
A ligand causes activation when it binds with higher affinity to the
active relative to the inactive state (see Figure 4.1A/B). If K A and K I are
the dissociation constants for the ligand binding to the active and inactive
states, respectively, then the ligand is activating if K A < K I . Moreover, the
fraction K I K A determines the activating potential of the ligand. When the
system is saturated with ligand, the free energy difference between active
eff
and inactive states becomes: ∆Ggap
= − RT ln (K I K A )+ ∆Ggap . For an ideal

activating ligand, K I approaches infinity, such that ligand saturation leads
to complete activation, and the degree of activation is only limited by the
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intrinsic ∆G gap . If a ligand binds to both states, the maximum degree of
activation is A = (K I K A )⋅

− ∆G

1 + e gap
− ∆G
1 + (K I K A )⋅ e gap
RT

RT

, and is limited by both the

intrinsic ∆Ggap and the ratio of equilibrium binding constants K I K A (see
Figure 4.1B). For a given protein (and a fixed ∆G gap ), this ratio of
equilibrium binding constants could differ for different ligands, leading to
varying degrees of activation upon ligand saturation. The specifics of a
biological process determine how large ∆Ggap needs to be and how it is
modulated by binding. Large ∆Ggap and K I K A lead to a high degree of
maximal activation (Figure 4.1B). A large ∆G gap is also useful in situations
with multiple effectors that act in a combinatorial manner.

Environment ∆Ggap can be modulated by environmental variables, such as
the membrane composition. While it may be possible to treat membrane
effects as ensembles of binding sites, we treat them as environmental
factors modulating ∆G gap in the simplest case.

Coupling Once the receptor ectodomain shifts into its active state, this
information is transmitted onto the functional cytoplasmic end of the
molecule. This is sometimes referred to as allostery and is equivalent to
stating that one end of the molecule is thermodynamically coupled to the
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other. This coupling depends on the specifics of the molecule’s structure
and dynamics, but can be thought of as arising from differences in interdomain interaction free energies when in different states. This interdomain coupling or allostery can therefore be captured with a
thermodynamic coupling free energy parameter, ∆∆Gc , which determines
the extent to which the different domains experience each other’s states.

Simple Model 1. A two-state extracellular receptor domain, with an energy
gap

R
∆Ggap
, receives input from a signaling ligand, which binds

preferentially to the active state of the receptor (Figure 4.1C). The receptor
domain is thermodynamically coupled, via the coupling parameter ∆∆GcR ,
to the cytoplasmic domain, which carries out the function of the system in
its active state. The intrinsic activity of the cytoplasmic domain is
C
. Figure 4.1D shows how the
controlled by its own energy gap, ∆Ggap

activity profile of this system (e.g. level of activation as a function of ligand
C
concentration) depends on ∆Ggap
and ∆∆GcR . Because the function of the

overall system is based on the activity of the cytoplasmic domain, high
values of its gap lead to low levels of background activity, thus more
C
switch-like behavior (compare profiles at low and high ∆Ggap
in Figure

4.1C). However, because the two domains are coupled, the energy gap of
the receptor domain also influences the level of activation. In fact, the
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energy gaps of the two domains can be thought of as jointly modulating
the overall effective energy gap of the system, as shown in Figure 4.1C.

Figure 4.1 Simple linked-equilibria models.
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(A) A thermodynamic cycle illustrating the coupling between activation of
a two-state protein and ligand binding. (B) Activation profiles of a two-state
protein as a function of an agonist ligand concentration. Ratio of
dissociation constants for the inactive and active states, K I K A , and the
intrinsic energy gap, ∆Ggap , determine maximal attainable activation. (C) A
diagram of a simple signal-transduction molecule. Two domains, a
receptor domain and a cytoplasmic functional domain, each with two
states, are thermodynamically coupled, with the receptor modulated by an
activating ligand. All eight states of the system are explicitly shown and
the indicated equilibrium free energy differences correspond to the
direction of the arrow with which they are shown. Free energy differences
between ligand-bound states (back side of the cube) are omitted for
simplicity, but follow simply from thermodynamic cycles. L indicates the
concentration of the cytoplasmic ligand. (D) Activation profiles of the
system in (C) as a function of the energy gap of the cytoplasmic domain,
C
, and coupling of the receptor to the cytoplasmic domain, ∆GcR . K A
∆Ggap
and K I are set to 10 nM and 20 µM, respectively, and the energy gap of
R
the receptor domain, ∆G gap
, is set to 3.0 kcal/mol. The effective energy

gap

for

this

shown
to
be
(1 + L K I )+ (1 + L K A ) − ∆∆G R . Thus, if
eff
C
∆Ggap
= ∆Ggap
R
R
c
gap + ∆∆G c ) RT
(1 + L K I )+ (1 + L K A )
e
∆∆GcR is zero (i.e. there is no coupling between the domain), the overall
 e (∆G
+ RT ln (∆G


system
− ∆∆GcR ) RT

can

be

R
gap

C
gap is just ∆Ggap
, but as long as ∆∆GcR is negative (i.e. activation of the
receptor promotes the active state of the functional domain), higher values
R
of ∆Ggap
contribute to a higher overall energy gap. Similarly, tighter

coupling (lower ∆∆GcR ), leads to a higher overall gap larger degree of
maximal activation.

Simple Model 2 If the TM domain has active and inactive states, the
system has 16 total states (Figure 4.2A), and the activation profile
depends on the energy gap of the TM domain and its coupling to the
cytoplasmic domain. Whereas larger energy gaps of the cytoplasmic
domain always lead to larger overall energy gaps of the system (i.e. larger
degree of maximal activation), this is not necessarily the case for the
energy gap of the TM domain (see Figure 4.2B), and the effect of
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TM
increasing ∆Ggap
can go in either direction, depending on the other

C
TM
parameters. Intuitively, this is because unlike ∆Ggap
, ∆Ggap
does not

directly modulate the activity of the functional cytoplasmic domain, but
TM
leads to
rather does so through thermodynamic coupling. Increasing ∆Ggap

lowering of the absolute active fraction of the cytoplasmic domain, by
virtue of the two domains being coupled. This serves to silence
background activity in the resting state, while in the presence of activating
ligand it limits the maximal fraction of active protein. The overall
consequence depends on which of these two effects dominates. Because
the TM domain lowers activity at resting state, it may provide higher levels
of activation compared to a system without a two-state TM domain (Figure
4.2B). This illustrates the advantage of having multiple loosely-coupled
domains – it allows for strong switching behavior without resorting to large
energy barriers between active and inactive states. Intermediate domains
also provide additional opportunities for modulation of the signal.
Additional environmental conditions, such as the state of the membrane or
the presence of specific ligands, can be integrated into the final output of
the signaling system.
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Figure 4.2 A more complex model of a signaling molecule.
(A) In addition to the receptor and functional cytoplasmic domains as in
Figure 4.1, here the TM domain is explicitly modeled as having two states.
TM
The intrinsic fraction of TM domain in the active state is defined by ∆Ggap
,
and it is coupled to the cytoplasmic domain via ∆GcTM . The sixteen states
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of the system along with the corresponding free energies are shown in the
TM
table on the right. (B) The dependence of activation profiles on ∆Ggap
and
∆GcTM . K A and K I are set to 10 nM and 20 µM, respectively, and values
of other parameters are shown. The line with circles demonstrates the
case where no two-state TM domain is present, and the receptor domain
R
as in other
couples directly to the cytoplasmic domain with the same ∆Ggap
models.

Simple Model 3 Extracellular and intracellular signals can be integrated
by the same receptor. The VirA/VirG two-component system from
Agrobacterium tumefaciens integrates multiple inputs with both its
extracellular and cytoplasmic domains, including plant phenolic signaling
molecules, monosaccharides, and pH(135). This can be modeled with the
addition of a two-state cytoplasmic linker domain (Figure 4.3A). An
intracellular ligand, such as a phenolic molecule, binds stronger to the
activated state than the inactive one (ligand C in Figure 4.3A), whereas a
different ligand, such as a sugar, modulates the states of the receptor
domain (ligand L in Figure 4.3A). Both the maximal activation as well as
the concentration of half-maximal activity (IC50) change for one ligand in
response to different concentrations of the other (Figure 4.3B). Such
cumulative modulation of activity by both ligands effectively amounts to
signal integration. It can be used by the cell to perform certain actions only
in cases, for example, where both ligands are present at certain
concentrations. In this case, both ligands were chosen to bind more tightly
to the active states of their respective domains, but repressing signals can
also modulate receptor function.
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Figure 4.3 A realistic model of signal transduction, inspired by VirA
protein of the VirA/VirG two-component system.
(A) In addition to the domains and states in the model presented in Figure
4.2, there is an additional cytoplasmic linker domain, with its own active
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and inactive states, which is modulated by the signaling ligand C, different
from ligand L which modulates the receptor. The total number of states in
this system is 64, and for clarity only the fully inactive and the fully active
states are diagramed. (B) Activation, relative to resting state, is plotted
against increasing concentration of ligand L, in the presence of different
concentrations of C. This illustrates the ability to integrate signals from
multiple ligands. Though this model does not explicitly treat the receptor
as being dimeric (as is the case for the VirA protein), it can be easily
extended to do so. In this case, binding of ligand may or may not be
coupled of receptor dimerization and there may exist cooperativity
(negative or positive) between the two ligand-binding sites. Potential
scenarios that can be explored include: 1) binding of a single ligand may
push the system towards the active state, whereas binding two ligands
symmetrically may favor the inactive state 2) alternatively, the receptor
may signal only when two ligands are bound, or 3) binding of the second
ligand may proceed independently of the first one.

Inside-to-Outside Coupling in Integrins Receptors
Integrins are α−β heterodimeric adhesion receptors that mediate
interactions between the extracellular environment and the intracellular
cytoskeleton (6, 95, 136-138) and demonstrate how bidirectional
transmembrane signal transduction is fine-tuned by multiple coupled
equilibria in the extracellular, transmembrane, and cytosolic domains
(Figure 4.4A). Integrin ectodomains contain a large globular N-terminal
ligand binding “head” and distinct C-terminal α and β “legs” that cross the
plasma membrane as single TM domains and terminate in short
cytoplasmic domains that bind intracellular molecules. The inactive
integrin adopts a bent conformation placing the head in proximity to the
membrane and the distal legs. Upon activation, an extended conformation
is favored and the α and β legs, TM, and cytoplasmic domains separate.
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Figure 4.4 Thermodynamic model of integrin signaling.
(A) At the coarsest level, extracellular, TM, and intracellular domains of
integrins can be thought as being either active or inactive, giving rise to
eight coupled states as illustrated. The various effector molecules
modulate integrin state by preferentially binding to select domain
conformations. “Inside-out” signaling refers to modulation of the
extracellular domain conformation via interactions between an integrin’s
cytosolic tails and intracellular signaling molecules. “Outside-in” events
sometimes refer to the activation of oligomerization dependent signaling
pathways subsequent to binding polyvalent ligands. However, keeping
with our model, here it will refer to the ability of extracellular ligands to
affect the conformation and function of intracellular domains. (B) Using
reasonable values for the energy gaps and coupling constants associated
with these states as well as equilibrium binding constants for the active
and inactive states of different effector molecules, one can interrogate the
thermodynamics of integrin signaling in a coarse, semi-approximate
manner. Shown here is the level of integrin activation (separation of
TM/tail regions) in response to increasing amounts of an activating
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antibody, as a function of Mn2+ concentration. This illustrates outside-in
signaling. (C) AND (D) Inside-out signaling as illustrated by the fraction of
extracellular domain bound to native ligand as a function of different
amounts of active intracellular talin and kindlin. The binding affinity of the
ligand as well as the amounts of talin/kindlin all couple to determining the
activation state of the integrin.
Interactions between the α and β chain legs, TM, and membrane
proximal cytosolic domains, stabilize the inactive integrin. Single point
mutations result in receptor activation (15, 18, 139, 140) and membrane
proximal abdisulfide cross-linking completely abrogates TM signal
transduction in either direction (141, 142). While structural studies suggest
that there is a distinct TM interface, the membrane proximal regions are
dynamic (15, 16, 40, 142, 143), befitting the need for rapid signal
transduction.
The “loose” dynamic interactions between the α and β chains near
the membrane give way to an extensive interface between globular
portions of the extracellular domain, which can be perturbed via
mutagenesis (144). Thermodynamic coupling occurs throughout the
globular ectodomain. Crystallization with and without ligand resulted in
active-extended (145) and inactive-bent (146, 147) conformations
respectively. Soaking the inactive crystals with a ligand resulted in only
small-scale changes in the binding site without leg extension due to crystal
contact constraints (148). Without such constraint, anti-integrin drugs can
generate adverse side effects by activating the receptor and generating
immune reactive epitopes or Ligand Induced Binding Sites (LIBS) in the
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integrin legs (138). Small molecule drugs can also uncouple subdomains.
Allosteric inhibitors that compete for inter-domain contacts generate
functionally split integrins in which the head is locked into an inactive
conformation, but distal regions generate active LIBS(149). LIBS
antibodies also shift the integrin equilibrium to an active conformation.
Constraining the integrin C-termini stabilizes the bent conformation and
the inactive ligand binding site, but the addition of LIBS antibodies and
Mn2+ (an second allosteric activator) shifts the head domain equilibrium to
an active state despite the distal constraints(150). Demonstrating
bidirectionallity, LIBS antibodies induce TM separation when not
constrained(18).

The combination of LIBS antibody and a second

activator, Mn2+, further increased activation, while Mn2+ alone did not
significantly affect TM separation. Therefore, as in the case of VirA/VirG
(Figure 4.3), multiple stimuli are integrated to produce different
intracellular responses (modeled Figure 4.4B).
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Figure 4.5 Coupled equilibria linking integrin TM interactions to
cytosolic events.
Integrin αβ TM heterodimers (left) stabilize inactive ectodomain
conformations and TM separation (right) stabilize active ectodomain
conformations. The αβ heterodimer stabilizes interactions between the βcytoplasmic domain and the inner leaflet of the bilayers (top). Cytosolic
proteins talin-1 and kindlin-3 shift the equilibrium towards an active
conformation by the stabilizing extended cytoplasmic domain and
separated TM domains (bottom right).

While the integrin cytoplasmic domain is much shorter (~5-6 kD for
β-integrins) than the ectodomain, it also integrates multiple signals to
modulate extracellular function. There is convincing evidence of a defined
αIIbβ3 TM interface, however, the membrane proximal and cytoplasmic
domains have not provided consistent structures (15, 16, 38, 39, 54, 151).
In Chapter 2, we describe the NMR structure and the dynamics of the αIIb
and β3 membrane proximal domains (1). The αIIb cytoplasmic domain
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was disordered, but caused a kink in β3 that was predicted to stabilize the
interaction of two β3 cytoplasmic helices with the bilayer. Significantly,
these dynamic membrane interacting helices contain the primary motifs
that bind the evolutionarily related talin and kindlin families of proteins
(reviewed in (20) and (19)). Figure 4.5 outlines a simple linked equilibrium
model, which is quantitatively described in Figure 4.4C/D, for how coupling
between talin and kindlin binding motifs allows differentiation between
ligands with different affinities for the receptor, effectively recapitulating an
intermediate affinity state without the need for distinct extracellular
conformations (149, 150). This model is further elaborated upon below.

IV.

Coupling between integrin and kindlin subdomains

produces distinct integrin activation states.
Our model of αIIbβ3 describes the integrin as series of
thermodynamically coupled subdomains (Figure 4.6A).
intrinsic

∆Ggap and

a

coupling

parameter

∆∆Gc

Each has an
that

describes

communication between subunits. The goal of this model is to
demonstrate that the presence of multiple intracellular regulatory domains
can result in a range of apparent extracellular affinity states that do not
require distinct ectodomain conformations. The studies reviewed above
107

demonstrate that there is interdomain communication in the ectodomain
that is coupled to the TM state. Our HDX results with model integrin
cytoplasmic domains demonstrate that despite its short sequence, there is
also communication between the TM and both the talin binding site and
the distal kindlin site. This establishes a path of communication from the
kindlin and talin sites to the ligand binding site.
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Figure 4.6 Simplified domain structure of αIIbβ
β3.
αIIbβ3 contains a series of thermodynamically coupled subdomains that
bind allosteric regulators. (A) The β3 chain was modeled containing six
subunits from the N-terminal ligand binding site (1) to the distal C-terminal
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kindlin binding site (6). Each subunit an intrinsic equilibrium (∆Ggap).
Adjacent subunits are thermodynamically coupled (∆∆GC). (B) With the
exception of the TM, each subdomain recognizes a specific ligand that
modulates the equilibrium between active and inactive conformations. In
the case of sudomain (1), the natural ligand would be fibrinogen.
Subdomain (2) includes the Mn2+ binding site (Mn2+ increases ligand
fibrinogen to αIIbβ3). Subdomain (3) can bind LIBS antibodies. The
combined active/inactive and ligand bound/ligand free states result in four
states per domain. The TM does not have a ligand and therefore has only
2 states. Talin-1 and kindlin-3 ind regions (5) and (6) respectively.

As actual thermodynamic parameters for each subdomain are
unknown, this model is mearly illustrative and intended to demonstrate the
functional effects of communication between integrin subunits and not to
make specific arguments as to their actual values. Thermodynamic
parameters were chosen to conform to published data when possible and
to fit with our experimental results. Without TM constraints, the integrin
ectodomain equilibrium lies only slightly towards the inactive state (150)
(152). Therefore a ∆Ggap of only 1 kcal/mol for each extracellular
subdomain was used. We assumed that the coupling energy between
subdomains was relatively high, lying between 3 kcal/mol and 6 kcal/mol.
The ∆Ggap for the TM domain was chosen to be 3 kcal/mol as this site is
the most sensitive to mutation and removal of the TM results in partial
activation. Each subdomain can bind a ligand with different affinities for
the active and inactive states. This ratio, K I K A , which was held to 1000
i.e. activating ligands prefer the active conformation 1000 fold more than
the inactive. Each subdomain can populate four states: 1) active without
ligand; 2) active with ligand; 3) inactive without ligand; and 4) inactive with
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ligand. The TM domain, does not have a ligand and populates only two
states, active (separated) and inactive (heterodimeric) states. The affinity
for talin-1 and kindlin-3 was assumed to be 100 nM, which is of the order
of magnitude observed in our ITC experiments in Chapter 3.

Thermodynamic coupling between extracellular, TM, and
cytoplasmic domains allows dynamic regulation of ligand
binding.
With no allosteric modulator, fractional occupancy of αIIbβ3 is
dependent on the intrinsic equilibrium of the receptor, ∆Ggap and ∆∆Gc ,
affinity for the ligand, and the ligand concentration (Figure 4.7A). Any
regulatory protein, such as talin-1, that binds preferentially to the active
conformation of the cytosolic domain will shift the extracellular ligand
binding curve to the left, increasing the apparent affinity of the receptor
(comparing Figure 4.7A and 4.7B). Likewise, a negative regulator can
stabilize the inactive conformation and shift the equilibrium to the right
(comparing Figure 4.7A and 4.7C).
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Figure 4.7 Binding of regulatory proteins to the integrin cytoplasmic
tail affects receptor occupancy.
The fractional occupancy of a model integrin receptor was plotted as as a
function of extracellular ligand concentration. Four different ligands were
modeled (Kd = 10 nM, solid; 100 nM, dashed; 1 µM, solid ball; 10 µM,
dashed ball). Thermodynamic parameters for integrin subdomains are
displayed to the right. (A) Receptor occupancy without a regulatory
protein. (B) Receptor occupancy in the presence of a distal activator such
as talin (KA = 100 nM, KI = 100 µM). (C) Receptor occupancy in the
presence of a distal inhibitor such as talin (KA = 100 nM, KI = 100 µM).
On the surface of platelets, αIIbβ3 is surrounded a high affinity
ligand, fibrinogen, which has a serum concentration between 5 and 10 µM,
well above its approximate Kd of 3-10 nM (153). Therefore, the intrinsic
equilibrium of the receptor must favor the inactive state strongly to prevent
spurious clotting and activation requires allosteric regulation via talin-1 and
kindlin-3. In the absence of communication between the intracellular and
extracellular domains ( ∆∆Gc = 0), receptor occupancy is independent of the
talin-1 concentration and depends only on the overall ∆Ggap of the
ectodomain, the ligand concentration, and the ligand’s affinity for the
integrin (Figure 4.8A). Coupling through the TM results in ligand binding
that is dependent on the concentration of active talin-1 (Figure 4.8B).
There is minimal binding to even strong ligands (Kd = 10 nM) in the
absence of talin-1, while receptor occupancy approaches 100% upon
talin-1 activation.

This produces switch-like behavior, in which the

receptor up-regulates affinity for a given ligand in the presence of minimal
background activity. Even weaker ligands, with affinities of 100 nM and 1
µM, have occupancies approaching 80% and 30%, respectively. If the
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coupling energy is reduced from 6 kcal/mol to 3 kcal/mol, then dynamic
range of the receptor decreases significantly.

There would be 50%

occupancy for a strong ligand (Kd = 10 nM) in the absence of talin and
90% occupancy at saturating concentrations of talin-1 (Figure 4.8C). A
slightly weaker ligand with an affinity of 100 nM would have approximately
10% occupancy in the absence of talin-1 and 40% at saturating talin-1
concentrations. The 1 µM ligand would have neglible binding even at
saturating talin-1 concentrations.
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Figure 4.8 Thermodynamic coupling between subdomains increases
ligand binding dynamic range.
The fractional occupancy of a model integrin receptor as a function of
talin-1 concentration in the presence of 10 µM extracellular ligand. Four
different ligands were modeled (Kd = 10 nM, solid; 100 nM, dashed; 1 µM,
solid ball; 10 µM, dashed ball). Thermodynamic parameters for integrin
subdomains are displayed to the right. (A) Receptor occupancy without
coupling through the TM. (B) Binding of ligands with affinities between 10
nM and 10 µM to the integrin with 6 kcal/mol coupling between
subdomains as a function of talin-1 concentration. (C) Receptor
occupancy with 3 kcal/mol coupling between subdomains as a function of
talin-1 concentration.

Coupling between talin-1 and kindlin-3 produces distinct
functional states.
The ability of cells to discriminate between different integrin ligands
has been attributed to the existence of distinct conformations in the
ectodomain (150, 154). However, this effect can also be produced by
coupling between multiple regulatory domains. To demonstrate this, weak
thermodynamic coupling was introduced between the talin-1 and kindlin-3
binding sites ( ∆∆Gc = 2 kcal/mol).

Binding of talin-1 (Figure 4.9A) or

kindlin-3 (Figure 4.9B) to the integrin cytoplasmic tail results in distinct
extracellular functional states.

Kindlin-3 produces much lower ligand

occupancy than talin-1, since its communication to the TM and the rest of
the receptor is dampened by the ∆Ggap of the talin-binding site. Already,
this produces two distinct extracellular states. The talin-only state has
higher occupancy than the kindlin-only state.

For example, in the

presence of 100 µM talin, the integrin would bind the 10 nM and 100 nM
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ligands with 90% and 50% occupancy, respectively (Figure 4.9A, black
line). In contrast, the same concentration of kindlin-3 would produce only
10% and ~1% occupancy, respectively (Figure 4.9B, black line).
Simultaneous binding of talin-1 and kindlin-3 to the integrin would produce
further activation states. For each talin-1 concentration (white/grey/black
bars) an increase in occupancy can be produced by the addition of kindlin3 (Figure 4.9A and 4.9C).

For example, if a cell were to activate both

talin-1 and kindlin-3, there would be 50% occupancy of a ligand with a 1
µM dissociation constant (Figure 4.9C, black line). By down regulating
kindlin-3, but maintaining the same level of talin-1, a cell could release the
1 µM ligand, but still bind higher affinity ligands (Figure 4.9A, black line).
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Figure 4.9 Multiple integrin regulators can produce diverse activation
states.
The fractional occupancy of a model integrin receptor as a function of
talin-1 or kindlin-3 concentration in the presence of 10 µM ligand. Four
different ligands were modeled (Kd = 10 nM, solid; 100 nM, dashed; 1 µM,
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solid ball; 10 µM, dashed ball). Thermodynamic parameters for integrin
subdomains are displayed to the right. (A) Receptor occupancy in the
presence of talin-1, without kindlin-3 binding. White, grey, and black
vertical lines mark 1 µM, 10 µM, and 100 µM of talin-1, respectively. (B)
Receptor occupancy in the presence of kindlin-3, without talin-1. White,
grey, and black vertical lines mark 1 µM, 10 µM, and 100 µM of kindlin-3,
respectively. (C) Receptor occupancy as a function of talin-1
concentration, with a constant kindlin concentration (5 µM). White, grey,
and black vertical lines mark 1 µM, 10 µM, and 100 µM of talin-1.
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Chapter 5. Conclusions
We hypothesized that cytosolic regulation of the integrin αIIbβ3 is
highly dependent on the membrane environment and uses coupled
equilibria to transmit signals to the extracellular compartment. To test this,
we studied the dynamics and structure of model αIIbβ3 cytoplasmic
domains in the presence of phospholipids and detergents (Chapter 2).
We showed that interactions in the integrin TM domain are coupled to
structural changes in the αIIbβ3 cytoplasmic domain.

The interaction

between αIIb and β3 stabilizes a kink in the β3 cytoplasmic domain, which
is likely to encourage interactions with the inner leaflet of the plasma
membrane. These interactions occur in two helical regions that include
the talin-1 and kindlin-3 binding sites.

This demonstrates that both the

talin-1 and kindlin-3 sites are coupled to the interactions between the αIIb
and β3 TM domains, suggesting a pathway whereby both talin-1 and
kindlin-3 can affect the TM state and therefore the affinity of the
ectodomain for fibrinogen.
We also investigated the interactions between αIIbβ3 and its two
regulators, talin-1 (Chapter 3) and kindlin-3 (Appendix A1). Preliminary
studies showed that kindlin-3 binds the distal segment strongly in the
absence of membrane.

The distal kindlin-binding sequence is very

dynamic and likely samples the cytoplasmic compartment frequently
(Chapter 2). This suggests that kindlin-3 may bind the β3 cytoplasmic
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domain without requiring a concerted interaction with the membrane,
though membrane colocalization could serve to increase its affinity. This
contrasts with talin-1.

We showed that talin-1 binding to the integrin

cytoplasmic domain is dependent on concerted interactions with the
bilayer as its affinity for β3 increases nearly 1000 fold when the integrin is
immobilized onto negatively charged membranes. Though the membrane
significantly increases the affinity of talin-1 for the β3 cytoplasmic domain,
its affinity for the integrin in the presence of membranes is not significantly
higher than its affinity for negatively charged phospholipids alone.
Similarly, we found that though talin-1 contains multiple lipid binding
subdomains and that the interactions between these subunits and the
bilayer are not cooperative. These results suggest that activation of the
integrin by talin-1 is not opitimized for extremely high affinity as would be
expected for perfectly cooperative interactions. Rather the energetics of
the system suggest that the interactions are evolved for reversibility and
sensitivity to changes in structure, post-translational modification, and lipid
environment.
Fine-tuning of the integrin cytoplasmic domain for regulation and
reversibility is befitting a receptor that must make dynamic interactions
with the extracellular environment.

Using a simple linked equilibrium

model, we showed that coupling between the TM and the talin-1 and
kindlin-3 binding sites can produce a range of extracellular functional
states. Different affinity states for extracellular ligands are due to a change

121

in the distribution of active and inactive states rather than adoption of
specific intermediate extracellular conformations. Integrins can access a
large range of affinity states by simply shifting the relative amounts of
talin-1 and kindlin-3 interacting with the cytoplasmic tail.
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Appendix 1. Preliminary investigations of the
interaction between kindlin-3 and αIIbβ
β3
I. Introduction.
Among FERM domain proteins, the kindlins (kindlin-1, kindlin-2,
kindlin-3) are evolutionarily the closest to the talin family. Like talin-1,
kindlin-3 binds to the β3 integrin cytoplasmic domain and is necessary for
platelet integrin activation (7-10, 22). As the role of kindlin-3 in integrin
function has only recently been appreciated, its mechanism of integrin
regulation remains largely unclear. Talin-1 and kindlin-3 F3 subunits bind
adjacent regions within the β3 cytoplasmic domain though it is unknown
whether they bind simultaneously (22, 155).

Talin-1 recognizes a

segment that spans from the end of the TM to Tyr747 and includes
TMproxH and CytoH1.

Kindlin-3 recognizes a distal segment that

immediately follows the talin-1 binding sequence, spanning from Ser752Tyr759, and including CytoH2 (Figure 2.5). Both proteins require intact
NPxY or NxxY motifs to bind (22, 155). The spacing between the talin-1
and kindlin-3 NPxY motifs is absolutely conserved in nearly all integrins,
with the exception of the β5 integrins.
Like talin-1, the kindlin-3 FERM domain contains an additional F0
subunit.

Whether kindlin-3 adopts a linear arrangement of like talin-1

(Figure 3.1) is unknown, since the structure of kindlin-3 has not been
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solved. The kindlin-3 FERM domain also contains an inserted pleckstrin
homology (PH) domain in its F2 subunit, which talin-1 lacks. The function
of the PH domain has yet to be demonstrated, though PH domains – and
FERM domains in general – are often involved in phospholipid interactions
(26).
Our HDX data suggest that the β3 cytoplasmic domain makes
significant interactions with the bilayer. In particular, the portion that binds
talin-1 is

significantly

phospholipids.

protected from

HDX in the presence

of

Furthermore, our NMR experiments show that αIIb

induces a kink in the β3 cytoplasmic domain, which is likely to orient the
β3 CT parallel to the membrane and further stabilize the interaction. We
also have shown that the interaction between talin-1 and β3 is quite weak
and requires a simultaneous interaction between talin-1 and the
membrane to be significantly populated. In contrast, our HDX and NMR
experiments have shown that the kindlin-3 binding sequence in β3, which
is connected to the talin-1 sequence by a flexible linker, is highly dynamic
and less helical and therefore less likely to bind the competing membrane
surface.

Based upon these results we hypothesized that the kindlin-3

sequence is more accessible than the talin-1 sequence, whether or not the
protein/peptide interaction is more thermodynamically stable.

A more

dynamic kindlin-3 binding sequence would also not adopt a particular
orientation relative the inner surface of the bilayer. This would suggest
that unlike talin-1, kindlin-3 binding to the integin might be less dependent
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on simultaneous interactions with the membrane. If this were the case,
then kindlin-3 might bind the β3 CT with reasonably high affinity in the
absence of membranes.

Below are initial experiments attempting to

characterize the interaction between kindlin-3 and β3 to test the above
model. We describe method for the purification full-length kindlin-3 from
platelets and demonstrate that kindlin-3 binds to the β3 CT in the absence
of bilayers.

These are initial experiments that are intended to be the

starting points for future lab members.

II. Results
Purification of kindlin-3 from human platelets.
Kindlin-3 constructs were cloned into the pet28a vector and
expressed in BL21-DE3 E. coli.

However, expression of constructs

containing full-length kindlin-3, the F2PHF3 subunit, and the F3 subunit
resulted in insoluble inclusion bodies.

We varied our expression

conditions with temperatures ranging from 8°C to 37°C and IPTG
concentrations ranging from 0.05 mM to 2 mM.

However, only the

isolated PH domain could be stably expressed in E. coli. We therefore
purified full-length kindlin-3 from outdated platelets.

Given its close

homology to talin-1 and its localization to membranes, it was likely that
kindlin-3 also contain positively charged surfaces. Therefore, the
purification scheme (Methods) was designed around separation based on
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charge. After several rounds of SP-Sepharose and size exclusion
chromatography, we produced nearly 10 mg of 95% pure kindlin-3 from
six units of outdated platelets (Figure A1.1A/B). The predicted molecular
weight for kindlin-3 is 75.4 kD and the purified protein had a calculated
molecular weight of 74 kD by equilibrium analytical ultracentrifugation
(Figure A1.1C).
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Figure A1.1 Purification of Kindlin-3 from platelets.
(A) Kindlin-3 was purified by several rounds of cation exchange
chromatography (Methods) and refined by size exclusion on an analytical
Superdex-200 column. (B) Analytical size exclusion chromatography
fractions were run on NuPAGE SDS 10% Bis-Tris gels and stained with
Coomassie Blue stain. Higher order aggregates eluted in the void volume
(Fraction 1). Kindlin-3 eluted between 13 and 15 minutes (Fractions 2-8)
and was found between the 66 kD and 97 kD bands of a Mark12
molecular weight standard. (C) Equilibrium analytical ultracentrifugation of
the purified protein. Kindlin-3 was prepared in 25 mM MOPS 100 mM
NaCl, pH 7 at 3 µM (left) and 1.5 µM (right). The samples were
sedimented at 15000 rpm, red/green, 20000 rpm, dark blue/black, and
25000 rpm, light blue/brown. Data were globally fit using the Igor software
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program to a MW of 74 kD. {AUC experiments were performed once.
Performed by DTM with the guidance of PB.}

Preliminary experiments suggest kindlin-3 binds β3 with high
affinity in the absence of bilayers.
Our HDX and NMR measurements of the β3 cytoplasmic domain
showed that the kindlin-3 binding sequence is very dynamic and likely
adopts many conformations relative to the membrane surface.

We

therefore hypothesized that, unlike talin-1 interaction with β3, kindlin-3
might not depend on a coordinated interaction with the bilayer surface. If
this were the case, then the complex between kindlin-3 and β3 should be
stable at much lower concentrations than the interaction between talin-1
and β3. We used analytical ultracentrifugation to measure the interactions
of labeled β3 with both talin-1 and kindlin-3 in the absence of membranes.
In each case 1 µM of BODIPY TMR labeled β3 CT (MW 6242 kD,
prepared as in Chapter 2 for FP) was sedimented in the presence of
excess kindlin-3 (3.5 µM or 1.75 µM) or excess talin-1 (10 µM). In the
presence of 10 µM talin-1, labeled β3 cytoplasmic domain sedimented
with an apparent molecular weight of 7.7 kD (Figure A1.2A), which is close
to its predicted monomeric 6.2 kD mass. In the presence of kindlin-3,
there was a clear shift towards higher molecular weight species. Global
fitting of both kindlin-3 concentrations resulted in estimation of a
dissociation constant between 100 nM and 3 µM (Figure A1.2B). Single
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species fits produced molecular weights of 43 kD and 12 kD for the 3.5:1
and 1.75:1 experiments, respectively, suggesting a Kd on the order of
several micromolar.

However, without higher concentrations of kindlin-3

and β3, it is impossible to calculate the affinity for β3 with higher accuracy.
This would require more kindlin-3 than could be prepared for the
experiment.
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Figure A1.2 Equilibrium AUC of Kindlin-3 and β3.
(A) Equilibrium AUC of 10 µM talin-1 and 1 µM BODIPY TMR-β3.
Sedimentation was monitored at 600 nm. The sample was sedimented at
four velocities (10000 rpm black, 15000 rpm blue, 20000 rpm green,
25000 rpm red). Data were globally fit to a single species of 7.7 kD using
Igor. (B)Kindlin-3 and BODIPY-β3 were combined in two ratios: 3.5 µM
kindlin-3 and 1 µM BODIPY-β3 (left) and 1.75 µM kindlin-3 and 1 µM
BODIPY-β3 (right). Sedimentation AUC was performed while monitoring
600 nm absorbance at three velocities (15000 rpm red/brown, 20000 rpm
dark blue/light blue, and 25000 rpm green/black). Sedimentation was
globally fit to a two species 1:1 binding model with the ε600 for Kindlin
held to 700 cm-1M-1 and ε600 for BODIPY-β3 held to 70000 cm-1M-1. Due
to the low protein concentration and absorbance relative to background,
sedimentation fit equally well to dissociation constants between 100 nM
and 3 µM. {AUC performed once by DTM under the guidance of PB.}

III. Methods
Kindlin-3 purification. Six to 10 units of outdated platelets (Hospital of the
University of Pennsylvania Blood Bank) were lysed by N2 bomb on ice in
the presence of mammalian protease inhibitors and 10 mM EDTA, 100
mM NaCl. EDTA was necessary to prevent significant proteolysis of
kindlin-3. Lysates were centrifuged at either 30k x g or 100k x g to clear
insoluble debris. After clearance, lysates were mixed with Q-Sepharose
batch-wise for 1 hour at 4 degrees Celsius to clear serum and negatively
charged proteins. The cleared lysate was loaded onto SP-sepharose (25
mL) in 50 mM NaCl batchwise and poured into a high-pressure FPLC
column for elution on gradient between 50 mM NaCl and 400 mM
Arginine, pH 7 on a Akta FPLC (GE Healthcare). The kindlin-3 containing
fractions were then concentrated and loaded onto a high resolution SP130

sepharose column (16/10, 25 mL bed volume) (GE Healthcare) and eluted
over a 400 mL gradient. At this point, the primary impurities were full
length talin and talin head domain, which were largely removed by size
exclusion on Superdex200 or Superdex75 analytical column (200 uL
injection volume) (GE Healthcare). A final high resolution SP sepharose
step was performed on a 400 mL gradient to 400 mM Arginine.

Equilibrium Analytical Ultracentrifugation.

Purified peptide and protein

samples were prepared in 25 mM MOPS 100 mM NaCl, pH 7.0.
Experiments were performed at 25°C. Samples were loaded into a 6channel carbon-epoxy centerpiece and centrifuged at 10000 rpm, 15000
rpm, 20000 rpm, and 25000 rpm in a Beckman XL-I analytical
ultracentrifuge. Samples were monitored at 280 nm and 600 nm in a 1.2
cm path length cell. The molecular weight and partial specific volumes of
kindlin-3 were calculated to be 75.4 kD and 0.73 ml/g, respectively using
SEDINTERP. The buffer density was calculated to be 1.003 g/ml. Data
were globally fit using Igor Pro (Wavemetrics).
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Appendix 2. NMR studies of the c-Src SH3 domain
and the β3 cytoplasmic domain.
I. Introduction
Src family kinases (SFKs) are a family of non-receptor tyrosine
kinases implicated in a number of biological processes (156, 157). There
are nine human SFKs expressed—often redundantly—in nearly all human
tissues (158). Of the SFKs, c-Src is the best studied, being discovered as
the first proto-oncogene in the 1970s (159). Redundancy in SFK paralog
expression has resulted in single-gene knockout phenotypes that are
unremarkable, especially in the case of platelets (158).

In order to

observe a significant platelet phenotype, it was necessary to generate
platelets deficient in six kinases (c-Src, Fyn, Fgr, Hck, Lyn, and Yes),
which resulted in reduced platelet spreading on the αIIbβ3 ligand
fibrinogen (160).

These gene-deleted platelets and wild-type platelets

treated with SFK inhibitors do not have a defect in integrin activation or
ligand binding.

Rather they have a downstream defect in tyrosine

phosphorylation and cytoskeletal mobilization after initial adhesion to
fibrinogen, suggesting that SFKs participate in platelet integrin outside-in
signaling, which is supported by the fact that SFKs are recruited to the
integrin associated cytoskeleton after platelet aggregation (161, 162) and
that c-Src activation requires binding of αIIbβ3 to fibrinogen (160).
SFKs contain well-conserved domain structures (Figure A2.1).
Each SFK contains an N-terminal membrane anchor followed by a flexible
132

linker (black), a Src Homology 3 (SH3, purple) domain, a flexible linker
(blue), a Src Homology 2 (SH2, green) domain, a flexible linker (yellow),
the kinase domain (orange), and then finally a C-terminal regulatory tail
(red).

Inactive SFKs adopt compact structures that are stabilized by

multiple intramolecular interactions
phosphotyrosine

recognizing

(163).

SH2

domain

In the inactive state, the
(green)

binds

to

the

phosphorylated C-terminal tail (red). The inactive conformation is also
stabilized by an interaction between the SH3 (purple) domain and a
second internal ligand in the linker (yellow) between the SH2 and kinase
domains. C-terminal Src Kinase (CSK) phosphorylates the C-terminal tail
(164), while protein-tyrosine phosphatase-1B (PTP-1B) activates the
kinase by dephosphorylating the C-terminus (165).

Activation also

requires phosphorylation of a regulatory loop in the kinase domain.
In the active state, the SH2 and SH3 domains are free to interact
with other proteins. Such interactions stabilize the active kinase state and
determine the localization of SFKs (156). Localization also depends on
the N-terminal membrane anchor.

All SFKs are myristoylated and a

subset are palmitoylated (166, 167).

C-Src is not palmitoylated and

contains a conserved patch of positively charged Arg and Lys residues
(Figure A2.1), which has been demonstrated necessary for binding of cSrc bilayers containing negatively charged phospholipids such as
phosphatidylserine and phosphatidylglycerol (25) (29).
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Figure A2.1 Domain structure of c-Src in its inactive conformation.
From N- to C-terminus: 1) N-terminal membrane anchor that is posttranslationally myrstoylated (Black). C-Src contains a stretch of basic
amino acids (bottom). 2) SH3 domain (purple) 3) Interdomain linker
(blue). 4) SH2 domain (green). 5) SH2-kinase linker (yellow) 6) Kinase
domain (orange). 7) C-terminal regulatory tail (red).
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SFK substrate specificity appears to be less dependent on the
substrate sequence than physical proximity (168). Therefore, the
specificity of SFK protein-protein and protein-lipid interactions is extremely
important in determining function. Recruitment to integrin signaling
complexes could potentially involve the N-terminal membrane anchor, the
SH3 domain, and the SH2 domain. Both the SH3 and SH2 subunits of cSrc have been shown to interact with Focal Adhesion Kinase (FAK) (169)
and p130Cas(170, 171), two proteins found in integrin signaling
complexes. A number of studies have also suggested that c-Src binds
directly to the last three residues (Arg760-Gly761-Thr762) of the β3
integrin cytoplasmic domain (23). Transgenic platelets containing
mutations in this region exhibited defects in spreading and down-stream
integrin events (137, 172). The Arg-Gly-Thr motif implicated in the c-Src /
β3 interaction is quite different from the canonical polyproline sequence
recognized by the c-Src SH3 domain (Figure A2.2B) (173).

The

polyproline backbone packs against a groove composed of aromatic
residues (Tyr93, Tyr95, Tyr139) (174, 175).

A specificity pocket defined

by Trp121 and Tyr134 is at the end of the aromatic groove and is flanked
by the n-Src loop and the RT-loop, which affect substrate specificity (173).
We hypothesized that the β3 cytoplasmic domain may bind to the cSrc SH3 domain either along the Tyr-groove or in the aromatic specificity
pocket.

We characterized integrin/SH3 interaction using biophysical

techniques sensitive to perturbation at these residues. We were surprised
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to find that the interaction is much weaker than predicted by published
biological and biochemical studies(23, 137, 172), suggesting that the
interaction may depend on other proteins or the lipid environment.

Figure A2.2. The interaction between the c-Src SH3 domain and a
polyproline peptide.
Interaction between the c-Src SH3 domain and a polyproline peptide
(yellow) is shown down the axis of the peptide (A) and rotated 90° (B).
The interaction requires packing of the polyproline backbone against an
aromatic groove and “specificity pocket” composed tyrosine and
tryptophan residues (purple). Residues from the RT-loop and the n-Src
loop interact with the backbone and side chains of the peptide and help
determine the sequence specificity of the interaction (PDB code 1nlp)

II. Results
C-Src, β3 integrin, and polyproline constructs.
The c-Src SH3 domain was cloned between residues Ala83 and
Ser143 into the pet28a vector with an N-terminal 6xHis tag followed by a
thrombin cleavage site for removal of the affinity tag. The β3 cytoplasmic
domain (β3-NITYRGT) between residues Asn756 and Thr762 was
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synthesized on Wang resin generating a short seven amino acid peptide
containing the Arg-Gly-Thr binding motif c-Src binding motif. Wang resin
was chosen because the resulting peptide contained a C-terminal
carboxylate like the natural sequence. The polyproline peptide Arg-ProLeu-Pro-Pro-Leu-Pro with a C-terminal amide was synthesized on Rinkamide resin.

Circular dichroism and Trp-fluorescence of c-Src SH3 domain
and the β3 C-terminus.
It has been reported that c-Src co-immunoprecipitates αIIbβ3, that
the SH3 domain interacts with the β3 C-terminus by ELISA with a
micromolar binding binding constant, and that mutations to the β3 Cterminal Arg-Gly-Thr sequence results in outside-in integrin signaling
defects (23, 137, 172). Though the integrin sequence is quite different
from the canonical polyproline ligand, we hypothesized that the interaction
might also occur along the Tyr-groove or the Trp-containing specificity
pocket. Changes in the local environment surrounding aromatic residues
can often be measured by changes in CD signal or Trp fluorescence
(176).

Binding of polyproline ligands to this region was previously

observed using these techniques (177) (178). We therefore attempted
similar experiments with our β3-NITYRGT peptide, reasoning that such
studies would support binding to the aromatic region of the SH3 domain.
Solutions containing 40 µM SH3 domain and 650 µM β3-NITYRGT
were prepared in pH 7.0 25 mM phosphate 100 mM NaCl. CD spectra
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were taken of each sample (Figure A2.3). The SH3 domain was then
mixed 1-to-1 with the β3-NITYRGT peptide and the CD spectrum of the
mixture was taken (Figure A2.3A, green). The expected spectrum for the
mixture in the absence of interaction was also calculated by averaging the
SH3 and β3-NITYRGT spectra (Figure A2.3A, green dash).

The

difference between the expected and experimental CD spectra was then
calculated (Figure A2.3A, red). There was no significant difference
between the two, demonstrating that mixing the β3-NITYRGT peptide and
SH3 domain resulted in no change in CD signal at the concentrations
used. However, when similar experiments were performed with 650 µM
polyproline RPLPPLP (Figure A2.3B), a clear shift in the CD was observed
(Figure A2.3B, red). The difference spectrum for RPLPPLP has a
maximum at 225 nm, which replicates previously published results (177).
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Figure A2.3 Comparison of CD and Trp fluorescence changes in the
presence of a polyproline peptide and β3-NITYRGT.
β
Protein and peptide samples were prepared in 25mM phosphate 100 mM
NaCl, pH 7.0. (A) CD spectra were taken of 40 µM c-Src SH3 domain
(dark blue), 650 µM β3-NITYRGT peptide (light blue), and a 1:1 mixture of
the two samples with 20 µM SH3 and 325 µM β3-NITYRGT (green). The
expected spectrum in the absence of interaction was calculated by
averaging the SH3 and β3 spectra (dashed green).
The difference
between the actual and expected spectra was calculated (red). (B) CD
spectra were taken of 40 µM c-Src SH3 domain (dark blue), 650 µM
polyproline (light blue), and a 1:1 mixture of the two samples with 20 µM
SH3 and 325 µM polyproline (green). The expected spectrum in the
absence of interaction was calculated by averaging the SH3 and
polyproline spectra (dashed green). The difference between the actual
and expected spectra was calculated (red). (C) Tryptophan emission
spectra of the c-Src SH3 domain. SH3 solutions with or without peptide
were excited at 295 nm and emission spectra were recorded from 300-400
nm. Spectra were recorded for 50 µM SH3 domain alone (light blue), 50
µM SH3 domain with 200 µM polyproline (dark blue), 50 µM SH3 domain
with 200 µM β3-NITYRGT (green), and 50 µM SH3 domain with 200 µM
polyproline and 200 µM β3-NITYRGT (magenta). {CD and fluorescence
experiments are representative of three independent experiments. Protein
and peptide samples were made by DTM. Experiments were performed
by DTM.}

Binding of a polyproline ligand to the c-Src SH3 domain results in a
blue shift in tryptophan fluorescence (178).

We reasoned that though

mixing of the c-Src SH3 domain and β3-NITYRGT did not result in a
significant change in circular dichroism, if the β3 peptide bound to the
tryptophan containing specificity pocket in the SH3 domain, it might induce
in a similar blue shift in fluorescence.

A 50 µM solution of SH3 was

excited at 295 nm and an emission spectrum was recorded between 300
and 400 nm, with an emission maximum at 355 nm (Figure A2.3C, light
blue).

The same measurement was performed on a second solution
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containing 50 µM SH3 and 200 µM β3-NITYRGT, with an emission
maximum at 356 nm (Figure A2.3C, green). In comparison, the addition of
200 µM RPLPPLP shifted the SH3 emission maximum to 347 nm (Figure
A2.3C, dark blue). Finally, the emission maximum for a sample containing
50 µM SH3, 200 µM β3-NITYRGT, and 200 µM RPLPPLP was at 346 nm.
These results show that unlike the polyproline peptide, the integrin
cytoplasmic domain peptide does not cause a blue shift in the SH3
domain Trp-emission spectrum. Likewise, it does not compete for binding
of the SH3 domain to the polyproline sequence.

NMR titration of the β3 cytoplasmic domain the c-Src SH3
domain.
Our CD and Trp fluorescence experiments did not demonstrate an
interaction between the c-Src SH3 domain and β3-NITYRGT at
concentrations as high as 350 µM β3-NITYRGT. We reasoned that the
interaction was either extremely weak and not observed at the
concentrations used or it might occur outside of the aromatic groove or
specifity pocket and therefore CD and Trp fluorescence would not be well
suited for the measurement. We chose to use NMR, which has
successfully been used to study weak protein-protein interactions (179).
The c-Src SH3 domain was expressed in

15

N M9 minimal media and

purified by nickel chromatography. The 6xHis tag was removed using
thrombin protease and the purified protein was transferred into pH 6.0
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phosphate buffer containing 100 mM NaCl and concetrated. Two NMR
samples were prepared for 1H-15N HSQC NMR. The first contained 1 mM
15

N SH3 (Figure A2.4, red) and the second contained 1 mM

15

N-SH3 and

15.7 mM β3-NITYRGT peptide (Figure A2.4, magenta). In the presence of
15.7 mM β3-NITYRGT, a number of SH3 residues exhibited changes in
chemical shift. The interaction appears to be in fast exchange, as only
shifts in peak location were observed. Slow exchange binding would be
expected to generate two sets of peaks corresponding to the bound and
unbound forms, while intermediate exchange would produce broadened
signals of both species with potentially a loss of intensity. In this titration,
peaks remained sharp and intense.

Figure A2.4 Changes in SH3 chemical shift in the presence of β3NITYRGT
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(A) 1H-15N HSQC spectra of samples containing 1 mM c-Src SH3 domain
(red) and 1 mM 15N-labeled c-Src SH3 domain with 15.7 mM β3-NITYRGT
(magenta). Both samples were prepared in pH 6.0 20 mM phosphate
containing 100 mM NaCl. {Samples prepared by DTM. Experiment
performed by DTM with help of HC.}
The difference in the HSQC spectrum for each residue was
calculated by the relationship ∆ppm = (∆1H2 +(∆15N/5)2)1/2 (Figure A2.5A).
The standard deviation for the per residue chemical shift change was
0.04. Sixteen residues had chemical shifts greater than one standard
deviation: Tyr95, Glu96, Arg98, Thr99, Glu100, Thr101, Asp102, Leu103,
Phe105, Asn115, Asn116, Glu118, Trp121, Ser126, Gly130, and Tyr134.
SH3 residues were color coded according to their chemical shift change
and mapped onto a previously reported structure of the c-Src SH3 domain
(Figure A2.5B/C). The majority of residues perturbed by β3-NITYRGT
were in the n-Src and RT-loops and centered around the specificity pocket
(Trp121 and Tyr134). The largest chemical shift changes occurred in
residues in or adjacent to the RT-loop, especially residues Arg98 (0.25
ppm), Glu100 (0.15 ppm), and Asp102 (0.13 ppm). Tyr93, Tyr95, and
Tyr139 form the aromatic polyproline binding groove (Figure A2.2,
magenta) that binds polyproline ligands. Of these, only Tyr95, which is
adjacent to the specificity pocket, was perturbed by β3-NITYRGT. Tyr93
and Tyr139 were unchanged (Figure A2.5B/C, magenta).
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Figure A2.5 β 3-NITYRGT causes chemical shift changes centered
around the SH3 specificity pocket.
(A) The change
NITYRGT (Figure
+(∆15N/5)2)1/2. (B)
onto a previously

in chemical shift in the presence of 15.7 mM β3A2.4) was calculated by the equation ∆ppm = (∆1H2
Chemical shift changes were color coded and mapped
solved NMR structure of the c-Src SH3 domain (pdb
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code 1nlp). The maximum chemical shift change was 0.25 ppm (red,
Arg98). The minimum cutoff was 0.05 (dark blue, Tyr95). Tyr95 is part of
the aromatic groove that binds polyproline ligands. The remaining
residues in the aromatic groove (Tyr93 and Tyr139) did not have
significant changes in chemical shift and are colored magenta.

The SH3 NMR sample containing 15.7 mM β3-NITYRGT was
serially titrated against the sample containing only SH3 domain.

This

produced NMR samples with constant 1 mM SH3 concentrations and β3NITYRGT concentrations ranging between 5.3 mM and 15.7 mM. HSQC
spectra were recorded for each sample. Figure A2.6A shows the change
in Arg98 chemical shift with the addition of β3-NITYRGT. The relationship
was linear (Figure A2.6B), indicating that the titration had not reached
saturation and that the majority of SH3 domain was unbound, even in the
presence of 15.7 mM β3-NITYRGT. Since the majority of the protein was
not bound, [SH3]total approximates [SH3]free and [β3]total approximates
[β3]free.

Therefore, the relationship ∆(chem. shift) = ∆ppmmax *

([SH3]free*[β3]free)/(KD*[SH3]total) simplifies to ∆(chem. shift) =[Ligand]*
(∆ppmmax/Kd). The term ∆ppmmax represents the change in chemical shift
when the SH3 domain is fully bound by ligand. As the slope is linear, it
can be assumed that the maximum chemical shift change is on the order
of 10 fold the observed change, or 2.5 ppm.

Since the maximum

reasonable change in chemical shift is 5 ppm for any protein-protein
interaction, this places the Kd between 175 mM and 350 mM..
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Figure A2.6
Src SH3.

1

N-15N HSQC titration of β 3-cytoplasmic domain and c-

(A) 1H-15N HSQC spectrum c-Src SH3 residue Arg98 backbone amide
without (red) and with 5.3 mM (yellow), 8.4 mM (orange), and 15.7 mM
(purple) β3-NITYRGT. (B) Relationship between Arg98 chemical shift
change and total concentration of β3-NITYRGT. The change in chemical
shift was calculated according to the equation ∆ppm = (∆1H2 +(∆15N/5)2)1/2.
The data was fit to a linear curve with a slope 0.0153 ppm/(mM titrant).
{Samples prepared by DTM. Experiments performed by DTM.}

III. Discussion.
Though SFKs are necessary for integrin outside-in signaling, how
they are recruited to these signaling complexes and the degree of
specificity built into the nine different kinases remains unclear.

SFKs

contain multiple subunits capable of making protein-protein and proteinlipid interactions, therefore targeting to a particular signaling complex
could potentially require the coincidence of multiple relatively weak
interactions.

There is clearly a degree of redundancy built into SFK

signaling in platelets as six kinases are required to be knocked out to
generate platelets that are unable to spread on fibrinogen. As a starting
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point for understanding the regulation of these processes, we have
investigated the interactions between c-Src and the β3 integrin
cytoplasmic domain.
We sought to characterize the interaction between the c-Src SH3
domain and the β3 integrin cytoplasmic domain C-terminus. Several lines
of evidence have suggested that the c-Src SH3 domain specifically binds
to the β3 integrin cytoplasmic domain. It has been shown that mutations
to the terminal Arg-Gly-Thr sequence result in decreased spreading of
both transfected cells (23, 180, 181) and platelets on a surface coated
with the αIIbβ3 ligand fibrinogen(137); that mutations to this sequence
disrupt co-immunoprecipitation of c-Src and αIIbβ3(160); that mutations to
this sequence block solid-phase binding of GST-SH3 domain to the β3
cytoplasmic domain (23, 181); and that a synthetic membrane permeable
peptide containing the Arg-Gly-Thr sequence disrupts platelet c-Src
signaling (182). The interaction was studied in solution using monomeric
c-Src and β3 constructs in contrast to the previously reported solid-phase
experiments, which used a dimeric GST-SH3 fusion protein(23). There
was no evidence of the interaction by circular dichroism or tryptophan
fluorescence and β3 did not compete with binding by a polyproline ligand.
It is possible that an interaction between β3 and the SH3 occurs away
from the canonical polyproline binding pocket, therefore we chose to study
the interaction by NMR. We found that addition of the β3 C-terminus does
in fact cause chemical shift changes in the SH3 domain in the region of
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the

specificity

pocket.

However

this

requires

extremely

high

concentrations of β3 and even 15.7 mM β3 does not saturate the SH3
domain and the calculated dissociation constant may be as high as
several hundred millimolar.
Typical polyproline ligands contain Lys or Arg residues that pack
against the Trp and Tyr in the specificity pocket and make electrostatic
interactions negatively charged residues provided by the n-Src or RT-loop.
The β3 sequence provides a conserved Arg residue at position 759 in the
Arg-Gly-Thr sequence and replacement of this sequence with a Glu-GlyLys is reported to disrupt c-Src signaling and interactions with β3 (181).
Further NMR studies are necessary with similar mutant peptides to
determine whether such a sequence substitution will also disrupt the
interaction seen by NMR.
Our measured interaction is much weaker than that reported for
binding of solid-supported β3. It is possible that the differences in the β3
cytoplasmic domain constructs used can account for the significant
variation between our results and those reported previously. We chose to
use the C-terminal seven residues for our NMR experiments as these
residues have previously been shown necessary for binding. The
discrepancy in apparent β3 binding affinity may partially be due to avidity
effects of surface binding by dimeric GST-SH3 fusion proteins (23, 181).
It is also possible a third species (or more) may be necessary for the
apparent interaction to occur under biological conditions. The adjacent
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sequence in the β3 cytoplasmic domain also recognizes members of the
kindlin and filamin families of protein and therefore could conceivably
cooperate in binding. C-Src also binds other integrin signaling molecules
including FAK (169) and p130Cas(170, 171). Further studies are needed
to characterize the recruitment of SFKs to integrin adhesions and to
determine whether the membrane environment plays a role.

IV. Methods

Protein and peptide constructs used. The c-Src SH3 domain was cloned
between Ala83 and Ser143 into a pet28a vector between the NdeI and
XhoI restriction sites.

Expression was performed in BL21-DE3 cells

(Novagen). They were grown in LB-media to an OD600 of 0.5 at 37°C
and 1 mM IPTG was added. After 3 hours of expression, cells were lysed
by tip sonication on ice for 20 minutes in pH 7, 500mM NaCl, 20mM
imidazole with a protease inhibitor cocktail (Sigma-Aldrich) containing 1
mM EDTA. The lysates were cleared by centrifugation at 30,000 g for 30
minutes. The supernatant was loaded onto a HiTrap Ni-NTA column (GE
Healthcare) and eluted over a 50 mL gradient to 500 mM imidazole.
Imidazole was dialyzed away overnight into pH 7.5 Tris, 100 mM NaCl, in
the presence of thrombin protease (GE Healthcare) to remove the 6xHis
tag. The SH3 domain then purified away from the 6xHis tag by DEAE ion
exchange chromatography.
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β3-NITYRGT was synthesized on Wang resin preloaded with a Thr
residue using a Symphony peptide synthesizer at 0.1 mM scale in 25%
DMSO/75% NMP with Fmoc-chemistry. β3-NITYRGT was N-terminally
acetylated and cleaved from the resin TFA/triethylsilane/water (95/2.5/2.5
v/v) for three hours and precipitated into dry-ice cold diethylether. β3NITYRGT was purified by reverse phase HPLC (Varian Prostar) using a
C4 preparative column (Vydac) on a water/acetonitrile gradient with 0.1%
TFA.
RPLPPLP was synthesized on Rink-amide resin using a Symphony
peptide synthesizer at 0.1 mM scale in 25% DMSO/75% NMP with Fmocchemistry. RPLPPLP was N-terminally acetylated and cleaved from the
resin TFA/triethylsilane/water (95/2.5/2.5 v/v) for three hours and
precipitated into dry-ice cold diethylether. β3-NITYRGT was purified by
reverse phase HPLC (Varian Prostar) using a C4 preparative column
(Vydac) on a water/acetonitrile gradient with 0.1% TFA.

Circular dichroism.

Purified c-Src SH3 domain was transferred to CD

buffer (mM phosphate 100 mM NaCl, pH 7.0) by dialysis and a stock
containing 40 µM protein was made (calculated by absorption at 280 nm).
Stocks of β3-NITYRGT and RPLPPLP were made in the CD buffer by
weighing out the respective peptides dissolving them in the appropriate
volume of buffer. CD spectra were taken on a JASCO J-810
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spectropolarimeter. Measurements were made stepwise for each 1 nm
between 215 nm to 240 nm and averaged over three scans at 25°C.

Tryptophan fluorescence. Stocks of purified c-Src SH3, β3-NITYRGT,
and RPLPPLP were prepared in CD buffer.

Three samples were

prepared: 50 µM SH3, 50 µM SH3 + 200 µM RPLPPLP, and 50 µM SH3 +
200 µM β3-NITYRGT. All fluorescence measurements were performed at
25°C in an Aviv Associates fluorometer. Samples were excited at 295 nm
using a 2 nm band-pass filter and the emission spectrum was measured
between 300 and 400 nm with 1 nm stepping and a 2 nm band-pass filter.

15N-1H HSQC NMR. SH3 grown in M9 minimal media supplemented
with 15N NH4Cl was transferred into pH 6.0 phosphate, 100 mM NaCl and
concentrated to 1 mM. NMR data were collected on a Bruker DMX-600
spectrometer equipped with a 5-mm x,y,z-shielded pulse-field gradient
triple-resonance probe (Bruker).

Experiments were performed at 20

degrees Celsius. Assignments were based upon published c-Src SH3
chemical shifts (175). 1H-15N HSQC were acquired and analyzed in the
Sparky software suite.

Changes in chemical shift were calculated

according to the relationship dCS = sqrt(dH2+(dN/5)2).
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